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ABSTRACT OF THE DISSERTATION 
FIBER SCAFFOLDS OF POLY (GLYCEROL- DODECANEDIOATE) AND ITS 
DERIVATIVE VIA ELECTROSPINNING FOR NEURAL TISSUE ENGINEERING 
by 
Xizi Dai 
Florida International University, 2015 
Miami, Florida 
Professor Wei-Chiang Lin, Major Professor 
Peripheral nerves have demonstrated the ability to bridge gaps of up to 6 
mm. Peripheral Nerve System injury sites beyond this range need autograft or 
allograft surgery. Central Nerve System cells do not allow spontaneous 
regeneration due to the intrinsic environmental inhibition. Although stem cell 
therapy seems to be a promising approach towards nerve repair, it is essential to 
use the distinct three-dimensional architecture of a cell scaffold with proper 
biomolecule embedding in order to ensure that the local environment can be 
controlled well enough for growth and survival. Many approaches have been 
developed for the fabrication of 3D scaffolds, and more recently, fiber-based 
scaffolds produced via the electrospinning have been garnering increasing 
interest, as it offers the opportunity for control over fiber composition, as well as 
fiber mesh porosity using a relatively simple experimental setup. All these 
attributes make electrospun fibers a new class of promising scaffolds for neural 
tissue engineering. Therefore, the purpose of this doctoral study is to investigate 
the use of the novel material PGD and its derivative PGDF for obtaining fiber 
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scaffolds using the electrospinning. The performance of these scaffolds, 
combined with neural lineage cells derived from ESCs, was evaluated by the 
dissolvability test, Raman spectroscopy, cell viability assay, real time PCR, 
Immunocytochemistry, extracellular electrophysiology, etc. The newly designed 
collector makes it possible to easily obtain fibers with adequate length and 
integrity. The utilization of a solvent like ethanol and water for electrospinning of 
fibrous scaffolds provides a potentially less toxic and more biocompatible 
fabrication method. Cell viability testing demonstrated that the addition of gelatin 
leads to significant improvement of cell proliferation on the scaffolds. Both real 
time PCR and Immunocytochemistry analysis indicated that motor neuron 
differentiation was achieved through the high motor neuron gene expression 
using the metabolites approach. The addition of Fumaric acid into fiber scaffolds 
further promoted the differentiation. Based on the results, this newly fabricated 
electrospun fiber scaffold, combined with neural lineage cells, provides a 
potential alternate strategy for nerve injury repair. 
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CHAPTER 1 Introduction 
1.1 Preface 
1.1.1 Nerve Injury 
The nervous system can be divided into two major sections: the central 
nerve system (CNS), which consists of the brain and the spinal cord, and the 
peripheral nerve system (PNS), which consists of the nerves that extend to the 
rest of the body from the CNS [1]. The CNS injury is usually caused by a stroke, 
a traumatic brain injury or developmental complications [2]. A stroke, also 
referred to as cerebrovascular accident (CVA), is the loss of brain function due to 
a disturbance (either ischemia or hemorrhage) in the blood supply to the brain [3]. 
Usually, it causes part of the brain to function improperly, leading to potentially 
severe consequences such as vision impairment, aphasia, or inability to move 
one or more limbs [4]. Traumatic brain injury (TBI) happens when the brain is 
traumatically injured by an external force. It is a major cause of death and 
disability worldwide, and it is usually caused by accidental falls, violence or 
accidents [5]. In case of developmental complications, when CNS is not properly 
developed resulting in abnormal tissue growth, the function of the CNS will be 
highly affected, leading to neurological disorders [6]. The major cause of PNS 
injury is trauma  [1]. Fragile nerves can be damaged by stretching, pressure or 
cutting, splitting the nerve into proximal and distal sections. When a nerve is 
damaged by stretching or pressure, the nerve fibers break while the surrounding 
tissues, which can be seen as an insulation, may remain intact. The proximal 
section is still viable while the distal section dies. After a period, the damaged 
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nerve may start the regeneration process. New nerve fibers may grow under the 
surrounding tissue until they reach the sensory receptor or muscle. When a 
nerve is cut, both the nerve and the surrounding tissues are severed. Without 
proper medical treatment, the growing nerve fibers could form a painful nerve 
scar, called neuroma. PNS injury interferes with signal transmission from the 
body to the spinal cord and the brain, causing loss of muscle functions, and loss 
of sensation in the injured area [7].  
Numerous researchers are attempting to find an effective way to treat 
nerve injuries. For CNS, spontaneous regeneration is quiet limited due to its own 
inhibitory environment [1]. These inhibitions emerge from the formation of glial 
scars and myelin-associated inhibitor factors. Therefore, researches are focusing 
on how to promote the regeneration ability of neural tissues. Delivering 
molecules such as morphogens, pharmaceutical drugs and microRNA (miRNA) 
to the injury site is a possible method. Neurogenesis has been seen in some 
animal studies but the benefits are limited due to the challenge of keeping the 
molecules present at the injury site at a specific and constant concentration [6]. 
Another treatment option is stem cell therapy. Briefly, it is the culturing of stem 
cells in vitro and then transferring these cells into the injury location. This method 
has the benefit of preventing glial scar formation and promoting neurogenesis 
originating from the patient, but also runs the risk of tumor development, low 
survivability of the stem cells and stem cell migration out of the injury site [1].  As 
for the PNS injuries, they are usually repaired by using either an autograft or an 
allograft. While this treatment procedure frequently provides a superior neural 
3 
 
functional recovery, it is also associated with significant drawbacks. For instance, 
the size mismatch between the recipient and donor nerves, the functional loss at 
the donor site, and the need of multiple surgeries are the common accompanying 
drawbacks of autografts [8]. For allografts, patients are exposed to the risk of 
immune/disease-related complications [8, 9]. It seems that no viable method to 
effectively treat neural injuries exists. Researchers are looking for new strategies 
to change the status-quo. 
1.1.2 Neural tissue engineering 
Tissue engineering has emerged as an excellent approach for 
regeneration of damaged tissue, with the potential to circumvent the limitations of 
current treatments [10]. Tissue engineering uses a combination of cells and 
biomaterials (scaffolds) to repair, maintain, or improve tissue function. Neural 
tissue engineering is a specific sub-field of tissue engineering. It is primarily a 
search for strategies to develop effective neural guidance aimed at bridging gaps 
in damaged peripheral or central neurons [1]. It delivers molecules to the injured 
nerves by embedding the molecules into the biomaterials; improves the stem cell 
survivability in vivo by supporting the cells growing at the injury sites; stops cells 
from migrating out by holding them within the scaffolds. Also, it does not have the 
side effects (size mismatch and function loss at the donor site) associate with 
autografts and limits the risk of immune/disease-related complications associated 
with allografts. 
A critical element in successfully producing functional tissue in vitro is to 
identify suitable biomaterials and use it to fabricate 3-D scaffolds that are 
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conducive to cell attachment, proliferation, differentiation and ultimately new 
tissue formation. Many methodologies have been developed to fabricate 3D 
scaffolds using biopolymers over the past [11]. Recently, micro/nanofiber-based 
scaffolds produced by using the electrospinning technique have been garnering 
increasing interest, as it offers an opportunity to control over the composition of 
the fibers, as well as over the porosity of the fiber meshes using a relatively 
simple experimental setup [12]. In additional to its high porosity and large surface 
area, a electrospun fiber scaffold provides a hierarchical structure highly 
resemble the extracellular matrix (ECM), an environment critical for cell survival, 
differentiation, signal transduction and nutrient/waste transport [13]. Moreover, 
electrospun fibers can be modified with different physical or chemical methods to 
encapsulate or attach bioactive molecules such as native ECM proteins to 
support and guide both the survival and differentiation of cells seeded on the 
scaffold. These attributes make electrospun nanofibers a new class of promising 
scaffolds especially for neural tissue engineering.  
The ultimate goal of this dissertation is to demonstrate that electrospun 
fiber scaffolds made from PGD and its modified derivative are able to support 
ESCs survival and differentiation into functional motor neurons using a newly 
developed protocol. To achieve this goal, a new class of electrospun fiber 
scaffold needs to be fabricated using a novel material poly (glycerol- 
dodecanedioate) (PGD) and its derivative poly (glycerol dodecanedioate co-
fumarate) (PGDF). The performance of these fiber scaffolds needs to be 
evaluated using human foreskin fibroblast cells and, more importantly, neural 
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lineage cells derived from embryonic stem cells (ESCs). The outcomes of the 
latter evaluation, if successful, will form a critical base for the development of an 
improved strategy for treating peripheral nerve injury. 
1.2 Background 
1.2.1 Scaffold 
As mentioned before, tissue engineering involves three important 
elements: viable cells, biomolecules and a structural scaffold. The scaffold 
serves as a foundation for the cells to grow and differentiate, and for the tissue to 
form. Different subtypes of tissue engineering require different biomaterials for 
tissue growing. Currently widely used biodegradable polymers such as poly 
(lactic acid) (PLA) [14], poly (glycolic acid) (PGA) [15, 16] and their copolymers 
are exceptionally stiff materials. For neural tissue engineering application, 
biodegradable elastic materials are desired in order to better match the 
mechanical properties of neural tissues. Therefore, a biodegradable polyester 
elastomer called poly (glycerol-dodecanedioate) (PGD) was developed by 
thermal condensation of glycerol and dodecanedioic acid (DDA) to meet this goal. 
1.2.1.1 Poly (glycerol- dodecanedioate) 
In the human body, cells efficiently build biological polymers from basic 
units such as nucleotides, amino acids and monosaccharides with the help of 
various enzymes. These nature polymers degrade back to original building units 
and could be metabolized in what is called the recyclable process. To efficiently 
produce a biocompatible and environmentally friendly polymer for tissue 
engineering, it makes sense to model after the natural process by utilizing 
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renewable and green starting materials with minimum waste generation, and 
performing the reaction in a relatively efficient way without using toxic solvents, 
hazardous chemicals and energy [17].  
The recent surge of interest in thermally crosslinked elastomeric polymers 
is largely due to the pioneering work of Robert Langer’s group, which in 2002 
introduced poly (glycerol sebacate) (PGS), a polyester which is analogous to 
vulcanized rubber [18].  Similar to PGS, Migneco et al successfully developed 
poly (glycerol dodecanedioate) (PGD) by thermal condensation of glycerol and 
dodecanedioic acid and demonstrated its unique shape memory property [19, 20]. 
PGD exhibits elastic properties similar to rubber and is biodegradable; therefore 
it is very suitable for soft tissue engineering applications. Dodecanedioic acid is a 
twelve-carbon substance with two terminal carboxylic groups, HOOC 
(CH2)10COOH. Even numbered dicarboxylic acids like sebacic acid and 
dodecanedioic acid can be metabolized to acetyl-CoA and enter the tricarboxylic 
acid (TCA) / (citric acid) cycle. Furthermore, the metabolic products of 
dicarboxylic acids, succinyl-CoA, is a gluconeogenetic precursor and TCA cycle 
intermediate [21]. Thus, some studies suggest that they could be utilized as 
alternative fuel substrate for enteral and parenteral nutrition, especially in 
pathological conditions. The most significant difference between sebacic and 
dodecanedioic acids is that sebacic acid will be quickly excreted from the kidneys, 
while dodecanedioic acid will not and is more suitable for the delivery of energy 
in enteral and parenteral nutrition [22].  
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Furthermore, PGD has one main characteristic that makes it unique 
compared to PGS. The glass transition temperature of PGD is 32 ˚C, which is 
above room temperature but below the physiological temperature. If PGD is 
deformed below the Tg, the material will be able to keep its new dimension 
resulting from the strain. However, if the elongation is induced above the Tg, the 
material will immediately recover its original shape. As a consequence, 
mechanical properties varied significantly based on temperature change. When 
temperature is above the Tg (37 ˚C), PGD achieved a Young’s modulus, rupture 
strain, and UTS of 1.08 MPa, 123% and 0.45 MPa, respectively. However, at 
room temperature, PGD displayed a vastly different mechanical profile: a 
Young’s modulus of 135.55 MPa, a rupture strain of 225%, and UTS of 0.45 MPa. 
In addition to shape memory properties, PGD displays many beneficial 
characteristics desirable for future in vivo biomaterial applications. In order to 
understand the in vivo applicability of PGD, the in vitro degradation rates were 
explored by Migneco et al  in 2009   [19]. By soaking polyester samples in PBS at 
37 ˚C for 20, 40, and 90 days, the mass loss due to hydrolysis was calculated. A 
negligible change in mass was observed after 20 days; only 6% mass loss 
occurred after 40 days. Over the course of the entire study (90 days), a total of 
13% mass loss was noted. For tissue engineering applications, which need a 
long time for natural tissue to populate on a PGD device, these results are 
considered ideal. For other application such as drug delivery, the hydrolytic 
lifetime of PGD can be shortened by varying the compositions and reaction 
conditions 
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As previously mentioned, glycerol is naturally occurring, with roles in lipid 
biosynthesis, gluconeogenesis, and glycolysis. Dodecanedioic acid is also 
endogenous to human metabolism, resulting from the ω-oxidation of lauric acid. 
Cytotoxicity of PGD was therefore expected to be minimal, as these monomers 
are compatible with biological systems. In order to explore this hypothesis, 
human aortic fibroblasts (HAFs) were seeded on PGD-coated glass slides and 
polystyrene plates [19]. The cell density on the polystyrene plates was higher 
than that of cells on PGD-coated slides for approximately 18 days. However, at 
that time point, the cell density on PGD surpassed the density of HAFs on 
polystyrene. Cell viability and growth were monitored with the WST-1 assay. 
HAFs were viable throughout the course of the study, with similar trends on PGD 
and polystyrene  [19]. 
1.2.1.2 Fabrication methods 
When fabricating scaffolds for tissue engineering, three methods are 
commonly used: phase separation, self-assembly and electrospinning [11]. 
Phase separation fabricates porous polymer membranes and scaffolds by 
inducing the separation of a polymer solution into a polymer-rich phase and a 
polymer-poor phase [23]. Self-assembly creates nanofibers that rely on weak 
noncovalent interactions to build nanofibers from small molecules, nucleic acids, 
proteins or peptides [24]. Electrospinning is time- and cost-efficient technique 
that produces long, continuous fibers based on the electrostatic repulsion of a 
polymer solution to form fibers [12]. Table 1.1 shows the advantages and 
disadvantages of each method.  
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Table 1.1 Three different scaffold fabrication methods and their 
advantages/disadvantages. 
Fabrication 
methods 
Advantages Disadvantages 
Phase 
separation 
Good for creating porous scaffolds. 
Simple, no special equipment 
necessary. Porosity is easily 
controlled. 
No organized pattern 
possible; limited 
number of polymers. 
Self-assembly Molecules undergo spontaneous self-
assembly into higher order structures. 
Requires engineering 
of molecules that will 
self-assemble; can 
only create short 
fibers. 
Electrospinning Can create aligned fibrous meshes. 
Can be used with biological polymers 
such as collagen. 
Can only create fibers.
 
The main mechanism of phase separation, as the name suggests, is to 
separate the phases due to their physical incompatibility. One of the phases, 
which is the solvent, is then extracted, leaving behind the other remaining phases 
[23]. It is simple and good for creating porous scaffolds, but pattern organization 
cannot be controlled. For neural tissue engineering, organized patterns are 
desirable, as they can better guide neural axon elongation. As to self-assembly, 
the fabrication process is challenging, limited to a few polymers, and can only 
create short fibers with lengths of one to several micrometer [24]. Comparing 
these three methods, for neural tissue engineering, electrospinning where the 
pattern can be controlled, and the fiber length can be adjusted to a few 
centimeters, is an appropriate choice. 
The basic principle of electrospinning involves a Taylor cone of solution, 
which is held at the orifice of a needle by applying high voltage between the tip 
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and the grounded collector. When the electrostatic repulsion in the solution 
overcomes the surface tension, a charged fluid jet is ejected out of the needle tip, 
traveling through the air with solvent evaporation, and finally deposited on the 
grounded collector. The syringe pump provides a continuous flow of the solution 
coming out of the spinneret and thus multiple copies of the electrospun fibers can 
be fabricated within a short period of time. During the course of leaving the 
spinneret and arriving at the collector, the charged jet undergoes stretching and 
whipping according to a number of parameters, which are broadly classified into 
solution parameters, process parameters and ambient parameters. 
The solution parameters of electrospinning include molecular weight, 
viscosity, concentration, conductivity, and surface tension. The molecular weight 
of a polymer plays an important role in determining the size and morphology of 
electrospun fibers. Generally, high molecular weight polymer solutions are more 
widely used in electrospinning as they come with the desired viscosity for the 
fiber fabrication. Studies have shown that a polymeric solution with low molecular 
weight tends to form beads or beaded fibers rather than smooth fibers [25]. In 
contrast, a solution with a high molecular weight would yield fibers with larger 
average diameters. Gupta et al. have utilized PMMA with various molecular 
weight to investigate the effect of molecular weight of a polymer on fiber 
morphology. They found that as the molecular weight increases, the number of 
beads decreases [26]. However, McKee et al. found that high molecular weight is 
not always essential for electrospinning, as long as sufficient intermolecular 
interactions can provide a substitute for the interchain connectivity obtained 
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through chain entanglements. Nonwoven membranes of oligomer-sized 
phospholipids, for example, were produced from lecithin solutions via 
electrospinning [27]. 
Viscosity of the electrospinning solution also has a significant effect on the 
morphology and size of the electrospun fibers. No continuous fiber can form if 
viscosity is too low. On the other hand, ejection of jets from a polymer solution 
with high viscosity is very difficult. Therefore, an optimal solution viscosity has to 
be determined in order to fabricate desirable fibers via electrospinning.  Fong et 
al. used polyethylene oxide (PEO) to investigate the effect of viscosity on fiber 
production, and reported that viscosities ranging from 1 to 20 poise were suitable 
for uniform nanofiber formation [28]. 
Polymer concentration is also critical to the production of fibers using the 
electrospinning process. At a low polymer concentration, the process produces 
beads, instead of fibers.  As the concentration increases, the shape of the beads 
changes from a spherical form to a spindle-like form and eventually the output 
becomes uniform fibers. If the concentration is too high, the formation of 
continuous fibers will be inhibited as it is impossible to maintain the flow of the 
solution at the tip of the needle. It should be noted that molecular weight of 
polymer, polymer concentration and viscosity are inter-related to each other. The 
polymer concentration is strongly related to the viscosity and this relationship has 
been studied with various polymers, including gelatin, poly (ethylene oxide) 
(PEO), poly (vinyl alcohol) (PVA), poly (methylmethacrylate) (PMMA), poly (L-
lactic acid) (PLLA), etc. [26, 29-32]. Normally, increasing polymer concentration 
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or viscosity gives rise to a larger or more uniform fiber size. In the electrospinning 
process, polymer concentration plays an essential role in determining the range 
of viscosities from which continuous electrospun fibers can be produced. Taken 
together, previous studies show that there are optimal polymer concentration 
values for electrospinning and that this property has a remarkable influence on 
the morphology and diameters of polymeric fibers [33]. 
The conductivity of an electrospinning solution is typically determined by 
the type of polymer, the solvent, and the availability of ionisable salts. Previous 
studies show that there is a marked decrease in electrospun fiber size with the 
increase of the solution’s electrical conductivity, and that with low conductivity, 
uniform fibers are not produced and beads may also be observed due to the 
insufficient elongation of the jet by electrical force [34]. Fibers with the smallest 
diameter can be produced with the highest electrical conductivity polymer and 
the decrease in the electrospun fiber diameter has been found to be due to 
increased electrical conductivity [34]. The morphology and diameter of 
electrospun fibers can be modified by adding ionic salts such as KH2PO4, 
NaH2PO4, and NaCl, e.g. beadless fibers with smaller sizes ranging from 200 to 
1000 nm were fabricated [35]. The same success has also been observed in 
other polymer types such as polyamide-6 [36], PVA [37], polyacrylic acid [38], 
PEO [28]. With addition of salts, the uniformity of electrospun fibers increases 
and bead generation decreases.  
Generally, reducing surface tension of the polymer solution leads to the 
production of beadless fibers in an electrospinning process. Hohman et al. found 
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that high surface tension inhibits the electrospinning process due to the instability 
of the jets and the generation of sprayed droplets [39]. A lower solution surface 
tension aids the electrospinning process in performing smoothly at lower electric 
fields; however, a lower surface tension is not always suitable for electrospinning 
[40]. The surface tension basically determines the lower and upper boundaries of 
the electrospinning window when all other parameters are constant [28, 37, 41]. 
The processing parameters of electrospinning include the applied voltage, 
the delivery rate, the distance from needle tip to collector and the collector types. 
There is always a threshold voltage in the electrospinning process to ensure fiber 
formation. When the applied voltage is above this threshold, a sufficient charge is 
induced on the solution and the electrospinning process is initiated. There is a 
dispute about the effect of the applied voltage on fiber diameter during 
electrospinning. Demir et al. claimed that by applying higher voltages, more 
polymer solution is ejected out of the needle and hence a larger diameter fiber is 
formed [42]. Other researchers suggested that increasing the electrostatic 
repulsive force by the increasing applied voltage will narrow the fiber diameters 
because it forces greater stretching of the solution in the fluid jet [43-45]. Another 
research group, Reneker and Chun reported there is no significant effect of the 
applied voltage on fiber diameter with electrospinning of PEO [46]. Therefore, the 
level of the applied voltage may influence fiber diameter, but its effect is 
modulated by other parameters such as polymer concentration, solution viscosity, 
and the tip-collector distance.  
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In the electrospinning process, a lower delivery rate is always desirable, 
as it leads to more time for solvent evaporation. However a minimum delivery 
rate of the spinning still has to be maintained in order to produce continuous 
fibers. Electrospun fiber diameter and pore size (determined by fiber diameter) 
increase as polymer solution delivery rate increases. If the delivery rate is too 
high, beads tend to form due to the lack of sufficient evaporation time prior to 
reaching the collector [47-50]. 
One crucial element of the electrospinning process is the collector type. It 
serves as the conductive substrate where the electrospun fibers are deposited. 
Nowadays, many types of collectors, such as rotating mandrel, are used in the 
electrospinning process [51-56].   
Another parameter to control fiber morphology and diameter is the 
distance between the needle tip and the collector; a minimum distance is 
required to provide sufficient time for solvent evaporation and produce fibers. It is 
also observed that a short distance between the needle tip and the collector 
leads to the formation of flat, instead of round, fibers [43]. However, the effect of 
this distance on the fiber size and morphology is not as strong as other 
parameters. 
In addition to the solution and the processing parameters, ambient 
parameters such as humidity and temperature also affect the output of an 
electrospinning process. Casper et al investigated the effects of humidity on 
producing polystyrene fibers via electrospinning, and found that increasing the 
humidity resulted in the appearance of small circular pores on the fiber mat and 
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further increase in humidity caused the pores to coalesce [57]. At very high 
humidity, the discharge of electrospun fibers is promoted. While at very low 
humidity, the solvent may dry too fast, and the electrospinning process is 
inhibited [58, 59]. The effect of ambient temperature on electrospinning 
polyamide-6 has been studied by Mit-uppatham et al and the results suggest that 
an increase in the temperature leads to a decrease in fiber diameter. Studies 
also found that there is an inverse relationship between the temperature and 
polymer solution viscosity [36].  
Electrospinning constitutes a unique technique for the fabrication of micro 
to nanometer fibers. The advantages associated with fiber scaffolds fabricated by 
electrospinning include time- and cost- efficiency, high aspect ratio, high specific 
surface area, and high porosity with a small pore size [12, 60, 61]. A variety of 
natural and synthetic materials such as gelatin [62], collagen [25], poly(ε-
caprolactone) (PCL) [41],  poly (D,L-lactic acid- co- glycolic acid) (PLGA) [15, 16], 
and PLLA [14] fibers have been successfully produced using the electrospinning 
process. These electrospun fibers will play a significant role in different tissue 
engineering areas and typical examples of which include neural, bone, cartilage, 
skin, tendon and ligament and cardiovascular tissue engineering [63-68].  
1.2.2 Stem cells and its differentiated neurons 
In the neural system, neuron or glial cell degeneration could lead to 
various clinical disorders. Nerve injury is a daunting challenge because most of 
these injuries result in irreversible loss of function. Therefore, another key 
element of neural tissue engineering is employing normal or genetically 
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engineered cells to repair injured locations. Different types of cells such as 
embryonic stem cells, induced pluripotent stem cells and neural stem cells have 
already been studied by researchers. 
1.2.2.1 Teratomas, pluripotent stem cells, and mouse embryonic stem cells 
Teratomas, a rare clinical tumor, is the beginning of the whole pluripotency 
story. It carried all three germ layers: ectoderm, mesoderm and endoderm, 
similar to what is found in a developing embryo [69]. Thanks to Stevens study [70]  
on spontaneous testicular teratomas and later the work of Kleinsmith [71]  and 
Pierce on teratocarcinoma, the embryonal carcinoma (EC) cell lines were 
developed and the mouse embryonic stem cells (mESCs) were finally 
established from the inner cell mass of mouse blastocysts in 1981 by two 
different groups[72, 73]. Initially, mESCs were cultured in conditioned medium of 
teratocarcinoma and feeder layer cells. Later on, Leukemia Inhibitory Factor (LIF) 
was identified and purified for maintaining the pluripotency of mESCs [74]. From 
then on, mESCs routinely maintained in labs became the working horse to help 
explore the unknown stem cell and developmental biology. 
1.2.2.2 Human embryonic stem cells 
Although the use of human EC cell lines in research dates back to 1970’s 
[75], the equivalent human embryonic stem cells (hESCs) was not established 
until 1998 by Thomson et al. [76]. The explanation of this technical delay in 
hESCs could be due to the different requirements of maintaining hESCs. Unlike 
the mESCs whose self-renewal is dependent on the LIF activated STAT3 
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signaling pathway [77], undifferentiated hESCs are maintained in the presence of 
mouse embryonic fibroblast feeders [76]. For the sake of maintaining hESCs in a 
feeder-free condition, condition medium from feeder cells plus Fibroblast growth 
factor-2 (FGF2) [78], high concentration FGF2 [79], or Transforming growth 
factor-beta (TGF-β), Nodal and Activin A [80, 81] had been used for supporting 
undifferentiated culture on Matrigel or other ECM coating plates.  
Furthermore, there are several differences between mouse and human 
embryonic stem cells, such as colony morphology and surface markers (SSEA1 
vs. SSEA3), even though they both share the same core regulatory transcription 
factors like Oct4, Sox2 and Nanog for pluripotency. Recent studies indicated that 
mouse and human embryonic stem cells may represent different developmental 
stages of pluripotent stem cells. Especially hESCs are more similar to mouse 
epiblast stem cells in terms of morphology, growth requirement and gene 
expression profiles [67, 82].  
Since the successful culturing of hESCs, those cells attracted the attention 
of the scientific community to explore their potential clinical applications based on 
investigating basic stem cell biology. The unique self-renewal and pluripotent 
properties of hESCs provide an unlimited cell source for tissue engineering and 
regenerative medicine.  
To date, the utilization of human embryos to create hESCs lines still 
presents ethical and political concerns, resulting in fervent debate regarding this 
area of research. Another concern for ES cell transplantation is the genetic 
differences between the ES cells and the patient; immunosuppression drugs may 
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be required to prevent rejection [83]. In order to develop patient- specific 
pluripotent stem cell, an alternative strategy called Somatic Cell Nuclear Transfer 
(SCNT), based on the early discovery of Goudorn’s study by replacing an 
oocyte’s nucleus with another somatic cell’s nucleus [84], had been proposed 
and demonstrated in mammals [85-87]. But this approach also faces the same 
ethical considerations for using human oocytes and destroying resulted embryos 
as well as technical challenges [88]. 
1.2.2.3 Induced pluripotent stem cells 
A recent exciting development of mouse induced pluripotent stem cells 
(iPSCs)  by Takahashi et al. [89] opened a new road for converting somatic cells 
to pluripotent stem cells. They carefully screened two dozens transcription 
factors that are highly expressed in ES cells and finally narrowed down to four 
key factors that are sufficient for reprogramming. By transducing four 
transcription factors (Oct4, Sox2, Klf4, and c-myc), also called ‘‘Yamanaka 
factors’’, into mouse embryonic or adult fibroblasts, these reprogrammed somatic 
cells exhibited mouse embryonic stem (ES) cell-like properties in terms of 
morphology, growth properties and gene expression patterns. In addition, they 
can form teratomas after injection into mice. After a few months, Wernig et al. [90] 
reached the same conclusion for mouse iPSCs with ES-like properties, and 
further showed that mouse iPSCs could form chimaeras as well as generate 
functional germ cells. 
In less than a year, Yamanaka’s group [91] demonstrated again that the 
same four transcription factors could be used to obtain human iPSCs. 
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Immediately, other groups confirmed this somatic cellular reprogramming 
feasibility [92-94] and demonstrated that other defined factors (Oct4, Sox2, 
Nanog, and LIN28) also worked [92]. It was concluded that human iPSCs and 
human embryonic stem (ES) cells are similar in regards to their morphology, 
growth, surface antigens, gene expression, and telomerase activity. Furthermore, 
these cells could differentiate into cell types of the three germ layers in vitro and 
form teratomas in vivo.  
Even though the efficiency of reprogramming iPSCs is still low and it 
exhibits some safety concerns of using viruses for delivery of exogenous genes 
and having the potential to form teratomas from undifferentiated cells, this 
technique still attracts a lot of scientific interest. Due to the simplicity and 
repeatability of iPSCs technology, multiple somatic cells and species have been 
tested and validated. The advancement of this technique resulted in explosive 
research activities in the past few years and is expected to accelerate the 
development of the use of iPSCs from patients for therapeutic purpose. One of 
the biggest advantage of using iPSCs is that the original source cells can be 
derived directly from patients. 
1.2.2.4 Neural stem cells, neurons and glial cells 
Due to limited access to human neural tissues, direct harvest of 
differentiated neural cell or adult neural stem cells is not always a viable choice. 
The characteristic properties of pluripotent stem cells are the capability of self-
renewal and differentiation into any cell type of three germ layers. Since the 
establishment of hESCs, a great deal of research have been made to explore the 
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potential of differentiating hESCs to clinically relevant cell population such as 
dopaminergic neurons for Parkinson’s diseases and motor neurons and/or 
oligodendrocytes for spinal cord injuries.  
Interesting observations of the pluripotent stem cell differentiation process 
seemed to recapitulate the major events in the embryo development. Thus 
carefully following the sequences of embryo development and providing the right 
combination of spatial and temporal signals normally led to specific lineage cells 
[95]. For the differentiation of pluripotent stem cells to neuroectoderm lineages, 
some studies have used conditioned media from stromal cells [96, 97], or 
induced the formation of 3D embryoid bodies. The early study results had 
indicated that in the absence of BMP signals, pluripotent stem cells would 
differentiate into neuroectoderm lineage in default [98].  Therefore, a chemically-
defined medium will help scientists identify the mechanisms with less 
interferences and accelerate the potential clinical application [99].   
Multipotent neural stem cells (NSCs) or neural progenitor cells (NPCs) are 
capable to differentiate into three major cell types: neurons, astrocytes, and 
oligodendrocytes. For research purposes or clinical applications, more specific 
subtypes of neurons and glial cells might be needed. For example, Wichterle et 
al induced the differentiation of motor neurons from ES cells derived NSCs by 
using retinoic acid and sonic hedgehog (SHH) analog [100]. Another clinically 
relevant dopamine neurons for Parkinson’s disease had been shown to 
differentiate from mouse [101] and human [102, 103] ES-cell derived NPCs in the 
presence of FGF-8 and SHH. In addition, Nistor et al. [104] demonstrated the 
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step-wise differentiation procedures for producing oligodendrocytes from human 
ES-cell derived oligodendrocyte progenitors.  
1.2.2.5 Motor neuron 
Motor neurons originate in the motor region of the cerebral cortex, have 
cell bodies in the spinal cord and axons that either directly or indirectly extend to 
control muscles.  It is clear that these cells have the potential to be very long, 
especially when providing impulses to muscles in distal regions.  In all 
vertebrates, motor neurons are cholinergic, thus releasing only the 
neurotransmitter acetylcholine, and a single motor neuron has the potential to 
innervate numerous muscles simultaneously.  In vertebrates, motor neurons can 
only provide an excitatory, contractile signal, and thus relaxation can only occur 
by inhibiting the motor neuron itself. 
  Motor neuron diseases are characterized as primarily affecting either the 
upper motor neurons or lower motor neurons [105].  Most often, motor neuron 
disease has a genetic origin, with the primary associated diseases being 
amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA) and 
bulbospinal muscular atrophy.  While in recent years there has been significant 
progress in identification, classification and pathogenesis of motor neuron 
diseases, there are still no available treatments for patients suffering from these 
degenerative pathologies.  Direct implantation of motor neurons derived from 
embryonic lines or induced pluripotent lines is still in the realm of science fiction, 
although the protocols are slowly improving.  Alternatively, deriving a 
pharmacological solution will require extensive testing on cultured motor neurons 
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or animal models.  This pharmacological, cell-based approach is far more 
clinically relevant at this time [106].  
Current neural induction protocols typically require protein introduction, 
conditioned media, feeder layers or SMAD signaling inhibition.  Each of these 
techniques has a significant drawback, such as poorly defined culture conditions, 
elongated time-course or low yield.   
The most typical motor neuron differentiation protocol requires the 
introduction of a protein called Sonic Hedgehog (SHH) in the presence of 
Retinoic Acid (RA).  The starting step of this protocol requires the creation of 
neuroepithelial cells from either ESCs or iPSC lines [107-109].  These 
neuroepithelial cells form tube-like rosettes in human cell lines over the first two 
weeks of culturing.  In mouse lines, these rosettes do not form.  The addition of 
SHH in the presence of RA induces the cells to form motor neuron progenitors 
which express OLIG2.  It has been recently found that the protein SHH can be 
replaced with the far less expensive small molecule PUR, with similar effects 
[110].  One week later, these progenitor cells develop into immature, HB9-
expressing motor neurons.  After another three to five weeks, functional mature 
human motor neurons can be identified.  
Instead of using this protein induction approach, the use of conditioned 
media has been identified as a viable alternative.  With this approach, it is 
necessary to culture the embryoid bodies in a conditioned media derived from 
the human hepatocarcinoma cell line HepG2 (Medll) [111]. Using this conditioned 
media at the embryoid body stage, neural precursors quickly emerged.  While 
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this approach is more complicated than the protein induction approach, due to 
the need for conditioned media from a carcinoma cell line, it demonstrates the 
novel possibility of using media conditioning as a technique for neural induction.  
Unfortunately, this technique does not currently allow the specification of the type 
of neuron derived unlike the more targeted protein induction approach.           
 Combining the approaches of protein induction and cellular conditioning 
forms the stromal feeder approach.  In this approach, embryoid bodies are first 
cultured on MS5 stromal feeders [112].  These feeder layers promote a quick and 
efficient generation of neural precursors, which following the introduction of SHH 
and RA creates spinal motor neurons.  The feeder layer approach has been 
proven to be effective in generating not only neural cells but also a wide range of 
glial cells.  While it is slightly quicker than the protein induction method on its own, 
its cost is significantly higher.            
 The final technique for discussion is the use of SMAD signaling inhibition.  
SMAD signaling plays a tremendous role during neural induction and recent 
studies have shown that particular elements of this signaling cascade, such as 
bone morphogenic protein (BMP) inhibitors, are critical during the neural 
organization phase of embryonic development [113].  This particular protocol 
utilizes the same steps as the protein induction explanation above, but also adds 
two additional molecules – inhibitors of SMAD signaling called Noggin and 
SB431542.  This protocol has been demonstrated to be robust and effective, as it 
generated a complete neural conversion of over 80% of human ESCs in 
adherent culture conditions. 
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1.3 Current research of cellular interactions on electrospun scaffolds for neural 
tissue engineering 
Central or peripheral nerve injury which cannot be directly repaired by 
end-to-end sutures is still a daunting challenge in clinical research. Nerve 
autograft transfers are the current gold standard for treating large nerve gaps but 
limited by shortage of donor nerve, donor site morbidity and inadequate 
functional recovery. A potential regenerative strategy is stem cell transplantation; 
however, less than 1% cell survivability is far from the minimal requirement [9, 
114].  To improve cell viability, stem cells can be transported via an artificial 
scaffold, which provides an environment conducive to survival after delivery. 
Electrospun nanofibers are well suited for this application as they can not only 
promote the neural cell differentiation but also enhance the axonal elongation. 
Neural cell proliferation and differentiation were shown to be affected by 
several properties of nanofiber scaffolds. Yang et al. studied the influence of fiber 
alignment on the differentiation of neural stem cells (NSCs) [14]. They fabricated 
aligned nanofibers by using a rotating disc as a collector. The results 
demonstrated that NSCs elongated and their neuritis outgrew along the 
orientated nanofibers. In another study, Xie et al. reported that aligned PCL 
nanofibers not only enhanced the differentiation of embryonic stem cells into 
neural lineage cells but also controlled the direction of neurite extension [115].  In 
addition, the diameter of fibers has been shown to affect NSCs differentiation and 
proliferation. Christopherson et al. claimed that as the diameter of fiber 
decreased, the NSCs showed more migration, spreading and proliferation [63]. 
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Furthermore, it was observed that the NSCs showed an increased rate of 
differentiation and proliferation on oriented nanofibers compared with microfibers 
[14].  
Some recent studies have proved that the conductivity of nanofibers can 
also influence the neural cell behavior. Ghasemi-Mobarakeh et al. obtained 
conductive electrospun nanofibers by mixing polyaniline (PANI) with poly (ε -
caprolactone)/ gelatin (PG). Electrical stimulation through 15%PANI/85%PG 
nanofibrous scaffolds showed enhanced NSCs proliferation and neurite 
outgrowth [116]. Cullen et al. fabricated nanofibers consisting of a blend of PANI 
and polypropylene as living neural-electrical relays.  This fiber scaffold shows the 
potential to promote primary dorsal root ganglion neurons adhesion, growth and 
neurite extension [117]. In another work, Liu et al. used Polypyrrole (PPy) 
substrates doped with chondroitin sulfate (CS) and conjugated with type I 
collagen. The collagen could self-assemble into 3-dimensional fibrillar matrix at 
the polymer surface. Their results showed that rat pheochromocytoma cells had 
an increased differentiation rate on the polymer substrates and electrical 
stimulation promoted the neurite outgrowth [118]. 
Other research groups have worked on incorporating proteins onto 
electrospun nanofiber scaffolds. Liu et al. investigated the feasibility of loading 
chondroitinase ABC (ChANS) and neurotrophin-3(NT-3) onto electrospun 
collagen nanofibers [119]. By using microbial transglutaminase (mTG) mediated 
crosslinking, the protein incorporating efficiency could reach 45-48%. Their 
results demonstrated that sustained release of NT-3 and ChABC through 
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collagen nanofibers can promote axonal regeneration and thus could be useful in 
spinal cord injuries treatment. Further, another research group immobilized EGF 
and bFGF onto PLLA nanofiber scaffolds and found significant enhancement of 
the axon growth [120].  Lee et al. coated PLGA nanofibers with PPy and 
immobilized nerve growth factor (NGF) on to the surface. These NGF-
immobilized PPy-coated PLGA scaffolds showed the supportive of PC12 neurite 
formation and outgrowth [121]. 
1.4 Research Plan 
The objective of this study is that electrospun fiber scaffolds made from 
PGD and its modified derivative are able to support ESCs proliferation and 
differentiation into functional motor neurons using the newly developed protocol. 
To complete the objective of this PhD research, several experimental 
studies (specific aim 1, 2 and 3) were designed and sequentially carried out.  
These studies reflect the progression of the development this PhD research, and 
hence become the frame work of this dissertation. 
In Chapter 2 of this dissertation (Specific aim 1), the development of an 
efficient and economical approach to direct the differentiation of ESCs to motor 
neurons is presented. The reason behind this development is that a large 
number of motor neurons is required to carry out a research project that aims to 
develop a new therapy for nerve injuries (i.e., the scope of this PhD research). 
Primary culture of motor neurons is not a feasible option here because the 
survival and proliferation of primary motor neurons tend to limited in an in vitro 
environment. 
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The use of ESCs is considered because they could, potentially, proliferate 
unlimitedly and can be derived into neurons as well as other neural cell types 
using different protocols. To successfully realize this idea, a small-molecule 
based methodology to differentiate ESCs into defined neural lineages in a fully 
controlled and efficient manner was developed. This protocol was tested with 
ESCs on the culture dishes as well as the electrospun fibers. 
In Chapter 3 (Specific aim 2), the focus will shift to scaffold building. 
Electrospinning is employed in this PhD research to fabricate fibers from polymer 
PGD, a new class of biodegradable and biocompatible polymers developed by 
Migneco et al  in 2009 [19], and its gelatin blended long fibers. The morphology, 
chemical structure, dissolvability and biocompatibility of the electrospun fibers as 
well as the effects of fabrication parameters on these characteristics are reported 
in this chapter. 
However, one disadvantage of the PGD polymer is that it is composed of 
saturated polyester chains that only have hydroxyl or carboxylic groups available 
for chemical modification. If another double-bond containing monomer is 
introduced, the resulting polymers with unsaturated polyester chains may provide 
new modification possibilities. These properties, in turn, can be used to modify 
PGD fibers and facilitate cell attachments. For this reason, fumaric acid, a non-
toxic, naturally occurring monomer, was incorporated into the PGD polymer 
synthesis process and produced a PGD derivative referred as poly (glycerol 
dodecanedioate co-fumarate) (PGDF) (Specific aim 3). It was combined with 
gelatin and PEO to fabricate electrospun fiber scaffolds. Both PGD and PGDF 
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based scaffolds were then used in a study of the growth and morphology of 
neural lineage cells to determine the effects of newly fabricated scaffolds on cell 
proliferation and differentiation. The results of this study are presented in Chapter 
4 of this dissertation. 
In the final chapter of this dissertation, a summary of the scientific findings 
of this Ph.D. research is provided, which supports the research hypothesis and 
demonstrates the success of this research project. In addition, a critical 
evaluation of the potential of this research project as well as a list of future work 
required to realize the ultimate goal of this research (i.e., developing a new 
therapy for nerve injuries) will be provided.    
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CHAPTER 2 Efficient and Low-Cost Differentiation of Embryonic Stem Cells into 
Motor Neurons by Metabolites for Neural Tissue Engineering 
2.1 Introduction 
As mentioned in chapter 1, efficient cell differentiation protocol is one of 
the important factors for neural tissue engineering. Other than the typical 
protocols for neuron differentiation mentioned previously, small molecule 
techniques have emerged in recent years to provide an inexpensive means of 
differentiating pluripotent or embryonic lines into motor neurons. This is 
accomplished most often by inhibiting or stimulating particular pathways that 
guide the differentiating cells into their final desired form.  Small molecules that 
have been used so far in recent literature in the generation of neurons include 
Dorsomorphin (DM), SB431542 (SB), CHIR99021 (CHIR), and Purmorphamine 
(PUR) [122].   
DM is an inhibitor of AMP-activated protein kinase (AMPK) and BMP 
signaling.  It is believed that DM assists neural induction by inhibiting BMP Type-
1 receptors ALK2, ALK3 and ALK6 [123].  In addition to the BMP-inhibition of DM, 
it has been recognized that SB must also be added due to its effect of inhibiting 
TGF-β.  SB has been shown to specifically inhibit TGF-β type 1 receptors, also 
known as activin receptor-like kinase 5 (ALK5) [124] while having no effect on 
BMP signaling.  The combination of these two small molecules allows initial 
neural induction.   
Neural induction is also maintained by inhibition of the Wnt- β pathway, 
carried out by using the small molecule CHIR. The Wnt- β pathway has been 
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implicated in neural crest induction but only recently has it been demonstrated 
that by inhibiting the pathway the ectoderm is able to expand the size of the 
neural plate [125]. When upregulated during this developmental phase, neural 
plate formation is not properly induced. Thus, it is clear that this pathway is 
another potential target for low-cost neural induction. 
 The final small molecule for discussion is PUR, which is currently used in 
recent literature (as well as in this particular study) as a replacement for the more 
expensive SHH. SHH is a well-studied morphogen and has been shown to 
contribute to floor-plate development within the neural tube.  Specifically, SHH 
has been shown to induce the differentiation of motor neurons and ventral 
interneurons [126].  Fortunately, PUR fulfills all of these same functions, and thus 
the addition of PUR is a crucial step when inducing neural cells towards a motor 
neuron lineage [110].  
While the previously described small-molecule techniques improve 
induction and differentiation efficiency, the metabolite techniques utilized in this 
study were mostly used to improve survival.  Specifically, Sodium Fumarate (NaF) 
and Genistein were applied to reduce oxidative stress and Sodium Butyrate 
(NaB), a histone deacetylase (HDAC) inhibitor, to promote neural cell 
differentiation. The use of these metabolites was both individually and collectively 
tested. 
NaF has been demonstrated to be both neuroprotective and 
cardioprotective through activation of the Nrf2 antioxidant pathway [127, 128].  
NaF is derived from Fumaric Acid, which is a metabolite and intermediate 
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product of the citric acid cycle [129].  Time-dependent and concentration-
dependent studies have been carried out that demonstrate NaF to be 
immunomodulatory and able to reduce oxidative stress without altering 
fundamental network activity [127, 128].  In vitro, its addition has been shown to 
improve neuronal survival.  In vivo, NaF works to better preserve the integrity of 
myelin, axons and neurons [129].  The choice to add it to this experimental 
protocol was due to a fundamental belief that its preservative ability would impact 
cell survival and induction efficiency.  
Genistein was chosen for a very similar reason, the reduction of oxidative 
stress, although it also aids in neural induction. Genistein is an isoflavone, a 
small molecule that has estrogen-like activity, and is believed to be useful as a 
preventative agent for hormone-related cancers [130].  Genistein is a secondary 
metabolite originating from plants, although its specific mechanism of action is 
unknown. It is also an inhibitor for protein phosphorylation at tyrosine residues, a 
process that researchers believe is responsible for neural differentiation [131].  In 
addition to its inductive ability, it has been proven to aid in neuronal cell viability 
and proliferation in vitro [132].  Genistein’s ability to modulate and reduce 
mitochondrial oxidative stress reduces neural apoptosis, even further supporting 
survival [133].  Similarly to NaF, Genistein was tested in this protocol due to its 
inductive and protective abilities.   
NaB was chosen for this study due to its role as an HDAC inhibitor and a 
metabolite. HDACs have been experimentally demonstrated to compact 
chromatin and silence genes, and are implicated in numerous dysfunctional 
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neuronal conditions, such as depression, addiction and memory problems [134] 
[26].  This same study examined the effects of inhibitions of different HDACs on 
mouse embryonic neurogenesis and demonstrated that the inhibition of HDACs 
by NaB inhibit BMP signaling and promote neurogenesis.  Thus, NaB acts 
similarly to the small molecule Dorsomorphin, referenced above.  NaB is a 
metabolite, however, and thus is more useful for controlling which metabolic 
pathways are activated.  While NaB has been studied generally in neurons, it has 
not been studied specifically concerning its impact on the survival and 
differentiation of motor neurons.  HDAC inhibitors have also been demonstrated 
to promote differentiation of embryonic stem cells into neural cells in adherent 
monoculture, but in a surprising reversal, they have also been demonstrated to 
assist lineage-committed oligodendrocyte precursor cells in converting into 
multipotent cells akin to neural stem cells [135, 136].  Due to its aid in inducting 
embryonic stem cells into neural lines, NaB was utilized in this study. 
These metabolites were essential to the study because of their roles as 
metabolites.  Each of the three just mentioned, as well as RA, are important 
intermediates or byproducts of metabolic mechanisms, and are thus important for 
upregulating or downregulating particular metabolic pathways.  RA is the active 
metabolite of Vitamin A and a powerful regulator of gene transcription [137].  
Vitamin A was chosen due to its effects on cell growth and immune function.  
NaF, the intermediate of the tricarboxylic acid (TCA) and Kreb Cycle, was 
selected since glycolytic metabolic mechanisms inhibit stem cell induction.  While 
NaB’s role as a metabolite is poorly understood, it has been demonstrated to 
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regulate acetyl-CoA synthesis [138].  Genistein’s metabolism mechanism is also 
not well documented, however its status as a metabolite is confirmed.  While the 
particular mechanisms by which these metabolites are used are poorly 
understood, they all have been individually linked to the downregulation of 
glycolysis and upregulation of oxidative phosphorylation that is typical to 
induction mechanisms. By using metabolites instead of other typical small 
molecules such as cytokines or growth factors, there is a potential to maximize 
the effect on the cell’s metabolic pathway while simultaneously reducing the input 
cost.      
  After indicating that each of these small molecules is a known metabolite, 
now it is the time to demonstrate why metabolic pathway modulation is the key to 
the motor neuron induction.  Stem cells are well known to have different 
metabolic mechanisms and requirements than differentiated somatic cells.  It is 
believed that stem cells alternate between self-renewal and differentiation 
through metabolic changes, modifying the mammalian target of rapamycin 
(mTOR) and AMPK pathways [139].  Since DM is a well-known AMPK inhibitor, 
metabolic modification may be a key component of its use in aiding neural 
induction.  Accumulating evidence has suggested that metabolites may be 
essential in modulating the cell signaling pathways and epigenetic regulation, 
and through using them, it is able to stimulate specific metabolic pathways that 
favor induction.     
Through these modifications, stem cells begin to favor aerobic glycolysis 
over oxidative phosphorylation.  ESCs specifically have a lower oxygen 
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consumption rate, less mitochondrial membrane potential and a higher 
concentration of glycolytic enzymes, thus favoring glycolysis [140].  The aerobic 
glycolysis cycle is subject to substantial energy demands due to the shortened 
cell cycle of the stem cells. In order to promote the stem cell differentiation, the 
energy production pathway was shifted away from glycolysis by using Dulbecco's 
Modified Eagle's Medium (DMEM) Low Glucose medium, which has been 
validated in previous literature [108].  The additional metabolites also contributed 
to the shift away from glycolysis.  Following the discussion of the results of the 
particular metabolite approach, potential metabolic mechanisms that aided motor 
neuron induction strategy will be addressed and how each metabolite was used 
to shift energy production towards oxidative phosphorylation will be proved.  It is 
believed that through understanding the metabolic underpinnings of stem cell 
differentiation, novel metabolite approaches can be easily derived to provide low-
cost approaches to stem cell differentiation.      
In this chapter, highly efficient and cost-effective production of motor 
neurons from mESCs through the application of metabolites (RA, Genistein, NaF, 
and NaB) was examined. These metabolites have not collectively been tested 
specifically with motor neurons until now and only RA has been used at all to 
induce this cell type.  
2.2 Experimental       
2.2.1 Motor Neuron Induction from Mouse Embryonic Stem cells 
Green fluorescent protein (GFP) -Expressing mESCs were purchased 
from GlobalStem. The procedure for maintenance of mESCs was as follows: The 
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mESCs were cultured on poly-L-lysine/laminin (Sigma-Aldrich, Fisher Scientific) 
coated culture dishes in embryonic stem cell growth medium (GM, DMEM-High 
glucose supplemented with 15% Fetal bovine serum (FBS), 10 ng/ml LIF, and 
0.1 mM β-mercaptoethanol).  Before neural induction, RA (1 μM, Sigma-Aldrich) 
was added into the GM for 24 hours (Day0). On day1, cells were cultured in 
neural induction medium (NIM, 1:1 mix of DMEM-Low glucose and F12 
supplemented with B27 (Invitrogen), 1μM Genistein and 0.25mM Sodium 
Butyrate (NaB) (All from Sigma-Aldrich) for 3 days. The medium was changed 
every day.  On day4, 1μM RA, 5 ng/ml SHH (PeProTech), 200μM Sodium 
fumarate (NaF) and 1μM Genistein were added for another 5 days for motor 
neuron induction. On day 9, RA, NaF, Genistein and PUR/SHH were removed 
from the medium and cells were cultured with 10 ng/ml brain-derived 
neurotrophic factor (BDNF, PeProTech), 10 ng/ml glial cell-derived neurotrophic 
factor (GDNF, PeProTech), and 0.5 mM Creatine (Sigma-Aldrich) for 2 days or 
longer.  
2.2.2 Functional evaluation of motor neuron differentiation 
2.2.2.1 Reverse Transcription-Polymerase Chain Reaction  
Total RNA was prepared from motor neuron differentiation cultures using 
SV Total RNA Isolation System (Promega). Each mRNA preparation was reverse 
transcribed into cDNA using olig(dT)15, as described by the manufacturer 
(GoScript Reverse Transcription System, Promega). Real-time Polymerase 
Chain Reaction (PCR) was performed on a Real Time PCR System (Applied 
Biosystems). For amplification, the cycling parameters consist of 1 cycle at 95 ˚C 
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for 2 min and 20 s, followed by 40 cycles of 95 ˚C for 3 s and 60 ˚C for 1 min. 
The comparative CT method was utilized to calculate the relative expression of 
each target gene, and each is normalized relative to the expression of 
glyceraldehydes-3-phosphate dehydrogenase (GAPDH) mRNA.   
2.2.2.2 Immunocytochemistry  
Motor neurons were subcultured on laminin-coated 35 mm dishes and 
fixed by using SafeFix (SafeFix™ II All-Purpose Fixative, Fisher HealthCare) at 
room temperature for 15 min. Immunocytochemical staining was performed using 
standard protocols and antibodies against MAP2(1:100; GeneTex), ChAT(1:50, 
GeneTex) and HB9 (1:50, Santa Cruz). Antibodies against β-Tubulin3 (E7; 
1:12.5), and Nestin (Rat-401; 1:5) were purchased from the Developmental 
Studies Hybridoma Bank. As secondary antibodies, donkey anti-mouse IgG 
(H+L), donkey anti-goat IgG-TR and goat F(ab)2 anti-rabbit IgG(H+L) (Southern 
Biotech) were used against the primary antibodies. Nuclei were counterstained 
with 4’, 6’-diamidino-2-phenylindole (DAPI, Sigma). Images were collected using 
a fluorescence microscope equipped with phase contrast optics and camera 
(Nikon). 
2.2.2.3 Evaluation of cellular viability 
Resazurin fluorescent dye (Sigma-Aldrich, St Louis, MO), which had been 
shown to be identical to the commercial assay Alamar Blue, was used as an 
index of cellular viability [141-144].  Briefly, 1:10 dilution of the reagent was 
mixed with fresh medium and added to each cell plate. Background controls of 1 
ml of medium plus 100 µl of the resazurin reagent were also performed. The 
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plates were placed in an incubator at 37 °C and 5% CO2 for 4 hours to allow the 
cells to metabolize the resazurin. Then, 100 µl medium samples from different 
cell plates were collected into a 96-well plate in triplicate.  Thereafter, the 96-well 
plate fluorescence reader was set to measure the fluorescence intensity of a 590 
nm emission with an excitation wavelength of 530 nm. The same procedure was 
repeated at different time points (day1, day3, day5, day7, day9 and day11).  The 
experiment was repeated three times and each individual group had three 
separate samples.  
2.2.2.4 Extracellular Electrophysiology 
For recording electrophysiological properties, a 35 mm plastic dish 
containing cultured motor neurons in growth medium was used.  Prior to 
electrophysiology measurements, cells were kept at 37 °C in a 5% CO2 incubator.  
The dish was quickly transferred to the stage of an inverted microscope for study.  
Cells were recorded within a dish containing the differentiation media.  The 
ground of the pre-amplifier was connected to the dish media and metal 
microelectrodes were slowly lowered inside.  The faraday cage was connected to 
the ground of the oscilloscope, which was located outside the faraday cage.   
To study the electrical characteristics of the motor neurons, extracellular 
electrical stimulation was used to depolarize the neurons, after which they 
generated action potentials typical of native tissue.  1 MΩ impedance metal 
electrodes (Eppendorf) were used to depolarize small clusters of neurons in the 
dish. These electrodes were connected to a preamplifier (A-M Systems) ,which 
was in series connected into an AC/DC Differential Amplifier (A-M Systems 
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Model 3000).  This amplifier has a gating feature, which allows the metal 
electrodes to be capable of both recording/amplifying a signal or transmitting 
electrical stimulation, depending on the voltage level of a trigger input.  To control 
the complex timing of the system, a Native Instruments Data acquisition (DAQ) 
Board (Native Instruments M-Series) was used. Once the DAQ Board sets the 
amplifier’s trigger into stimulus mode, it triggers a pulse stimulator (A-M Systems 
Isolated Pulse Stimulator Model 2100) to send a depolarizing pulse through the 
amplifier and electrodes into the dish.  Immediately following the pulse, the DAQ 
board sets the amplifier into recording mode and records a five-second signal at 
50k Hz.  All software to handle the timing was composed and executed in Matlab. 
  To depolarize the motor neurons, a pulse of length 0.2 ms was used.  To 
determine the proper voltage/current to depolarize the cells, a low current of 30 
µA was used for stimulation and was raised in steps of 10 µA until a signal was 
seen.  The amplifier was kept at a constant bandwidth of 300 – 20k Hz and an 
amplification of 1000. A notch filter at 60 Hz was used to eliminate line noise. 
2.3 Results 
2.3.1 Efficient motor neuron induction from embryonic stem cells  
2.3.1.1 Schematic procedures of motor neuron differentiation 
The procedure for motor neuron induction is schematically summarized in 
Figure 2.1A. Immediately after plating the mESCs (Figure 2.1B), a 24-hour RA 
treatment was applied. This novel strategy was adopted to promote the epithelial-
mesenchymal transition (Figure 2.1C).  Following this treatment, a combination of 
Noggin, Genistein and NaB was applied for 3 days to promote the establishment 
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became flat. (E, F) Neural stem cells were cultured in the presence of RA and SHH for 2 days 
and 5 days. (G) Two days of axon elongation promotion. Scale bars: (B-D) 100 µm; (E-G) 10 µm. 
 
2.3.1.2 RA Increases the Cell Viability and Restricts ESCs into Neuronal Lineage 
The novel use of RA for a 24-hour incubation step on day 0 provided 
significant improvement in cell viability and transformational efficiency.  Figure 
2.2A showed that the application of RA treatment reduced the expression of the 
essential pluripotency factors Oct4 and Sox2 compared to the control group. The 
difference between the decrease of Oct4 and Sox2 indicated that the expression 
balance of these two factors was disturbed, which broke the maintenance of the 
mESCs pluripotent state and leaded cells down the neural ectodermal cell 
lineage (Figure 2.2B).  After RA treatment, the mESCs started to lose typical 
colony morphology and the cells began to migrate away from the colony. The 
Immunocytochemistry images in figure 2.2C clearly showed that the control 
group has more Oct4+ and Sox2+ cells than the experimental group.  However, 
the high expression of pluripotent stem cell markers implied that most cells are 
still not differentiated for day 0 RA treatment, but initiate the differentiation again 
upon the second wave of RA treatment. Therefore, this result suggested more 
RA treatment (also see the reference) for the low Pax6 expression is necessary. 
By examining differentiation markers, upregulation of NE cell lineage was 
confirmed (Figure 2.2D).  Pax6 was expressed at comparable levels in RA and 
control groups from day 1 to day 3, but between day 3 and 5, the control group 
began expressing it at higher levels than the RA group.  This trend reversed from 
day 5 to day 7.  When examining the expression of Nestin, it is clear that the RA 
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group produced it significantly more from day 1 to day 5.  After day 5, Nestin 
expression grew exponentially, far faster than in the control group.  This may 
indicate that the use of RA on day 0 has its most profound impact on Nestin 
expression only when the neural stem cells are differentiating into precursor 
motor neurons.  MAP2 and DCX, both neural markers, demonstrated similar 
trends in the quick growth of their expression levels in the RA group that far 
outpaced the expression of the control group from day 1 to day 7.  All four of 
these markers are indicators of an ectoderm differentiation pathway and are thus 
desired to grow in intensity to demonstrate neuronal lineage. T represents 
mesoderm marker, which was never significantly expressed, indicating that the 
pathway was never pursued. Endoderm marker Sox 17 was expressed higher in 
RA group than control, indicating that RA may also promote endoderm 
expression.     
After examining the cell viability, as measured with Resazurin, every other 
day for 11 days, it is clear that the RA treatment strongly promoted the survival of 
the cells over the control group (Figure 2.2E).  It is intriguing to recognize that the 
only significant difference in cell viability between the experimental and control 
groups happened on days 1, 7, 9, and 11.  This data indicates that the cell 
viability is not significantly different during the neural stem cell stage, but grows 
to significance during the precursor motor neuron and mature motor neuron 
stages. It could indicate that the cell is far more susceptible to apoptosis during 
motor neuron induction, and thus the addition of RA on day 0 and later may have 
a protective long-term effect for the experimental group.   
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Figure 2.2. Effects of RA introduction on mRNA expression, transcription factors and viability. 
Expression of pluripotency (A,B) and differentiation (D) Primers in mESCs were assessed by real 
time-PCR. (A, D) The gene expression level were normalized to the house keeping gene GAPDH 
expression level. (B) Normalized the gene expression level of RA treatment group on day 1 to 
day 0. Average values and standard errors are from two replicate experiments. (C) RA 
significantly decreased the protein expression of the pluripotency factors.  (E) RA increases the 
Cell Viability. Scale Bar: 100 µm. Sample number in each group, n=3. Average values and 
standard errors are from three replicate experiments, *p<0.05 
 
2.3.1.3 The Effect of NaB on the Conversion of ESCs into Neural Stem Cells. 
The impact of NaB was examined using real time PCR and 
Immunocytochemistry.  After the fourth day of the protocol, the expected neural 
stem cell marker Nestin and neural marker MAP2 were expressed 25% and 37% 
higher than the controls, respectively (Figure 2.3A).  The mesoderm marker T 
was consistently expressed below control levels and the endoderm marker 
Sox17 was expressed at the same levels as controls by day 4.  Examining the 
results of Immunocytochemistry on day 4 it is clear that the neural stem cell 
marker Nestin is far more highly expressed in the NaB trials (Figure 2.3B).      
 F
E
a 
th
S
2
G
(m
g
h
d
c
igure 2.3. Na
xpression of 
fold change 
ree replicate
cale Bar: 10 
.3.1.4 Cont
eneration. 
The 
etabolites
roup were 
ighly upreg
ropped bel
ontrol in 
B treatment 
differentiation
relative to th
 experiments
µm. 
inued Pres
effects of
 group) on
examined 
ulated on
ow the con
the metab
induces neur
 primers in m
e control (eq
. *p<0.05 (B
ence of Ge
 simultane
 motor ne
(Figure 2.4
 day 7 in 
trol on day
olites gro
44 
al stem cells
ESCs was a
ual to 1). Av
) Immunocy
nistein and
ous addit
uron gene
A).  Motor 
metabolite
 9 and wa
up. Motor 
 differentiatio
ssessed by 
erage values
tochemistry o
 NaF Prom
ion of G
ration as 
neuron pre
s group c
s expresse
neuron m
n of embryo
real time-PC
 and standa
f Nestin and
otes Moto
enistein, N
compared
cursor ma
ompare to
d 2.8-fold 
arker ISL
 
nic stem cell
R and is show
rd errors are
 DAPI on d
r Neuron 
aB and 
 to the co
rkers Olig2
 the contr
higher than
1 was h
s. (A) 
n as 
 from 
ay 4. 
NaF 
ntrol 
 was 
ol. It 
 the 
ighly 
45 
 
expressed on day 7 while motor neuron marker HB9 was drastically upregulated 
on day 11 in metabolites group. ChAT, a mature motor neuron marker, 
consistently displayed a significantly higher expression compared to the control 
group, indicative of the fact that the use of this array of metabolites can quickly 
create mature motor neurons.   
Representative staining in metabolites and groups using antibodies 
against MAP2, ChAT and HB9 are demonstrated in Figure 2.4B through 
Immunocytochemistry.  Examining the results of Immunocytochemistry, it is clear 
that HB9 and ChAT are far more strongly expressed in the metabolites group 
than in the control group.  Ratios of HB9+ and ChAT+ cells are significantly 
different between control and metabolites treated group (Figure 2.4C). 
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Figure 2.4 Continued presence of Genistein and NaF promotes motor neuron generation. 
(A) The expression of MN specific genes such as ISL1, Olig2, HB9, ChAT were upregulated by 
the treatment of metabolites. The genes were shown as a fold change relative to the control 
(equal to 1). (B)  Immunocytochemistry images of MAP2, HB9 and ChAT positive cells in both 
groups on day 11. Scale Bar: 10 µm. (C) Metabolites treatment greatly increased HB9+ and 
ChAT+ cells. Average values and standard errors are from three replicate experiments, p<0.05 
2.3.1.5 Effects of Various Combinations of Three Metabolites 
While the previous results demonstrate the efficacies of Genistein, NaB 
and NaF, additional tests were performed to determine the effects of any 
interactions and the ideal combination, if one existed.  Fundamentally, whether 
particular combinations of these three metabolites would be ideal in maximizing 
mature motor neuron differentiation efficiency and viability were studied.   
To analyze the effects of specific combinations of the metabolites, the 
expression of different markers including Olig1, GFAP, Olig2, ISL1, HB9 and 
ChAT were measured (Figure 2.5). Olig1 and GFAP are Oligodendrocyte and 
Astrocyte markers, respectively, and expression of them was undesired for the 
purposes of this experiment.  Surprisingly, the combination of Genistein and NaB 
specifically generated a large quantity of GFAP expression.  The most desired 
expression marker was ChAT, which indicates a mature motor neuron.  It is clear 
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Figure 2.6. Efficient generation of motor neurons by PUR. (A) Quantitative real time PCR 
analyses (day 12) indicated expression of motor neuron progenitor and motor neuron markers by 
differentiated neural stem cells that were cultured with RA or PUR from day4.  Values provided 
are relative expression levels compared to control group values, which are normalized to 1 (B) 
Immunocytochemistry images of PUR trial showed similar protein expression level of 
neural/motor neuron markers. Average values and standard errors are from three replicate 
experiments. Scale Bar: 10 µm 
2.3.1.7 Functional Features of ESC derived Motor Neuron. 
The presence of an action potential that mimics native neuron is one of 
the clearest indications of the success of the culturing and cell-type derivation 
strategy.  Each action potential recorded occurred following the stimulus, after 
which baseline voltage levels were reacquired and maintained. The resting 
potential of each of these trials immediately prior to the action potential averaged 
to -72.3 mV, almost a perfect mimic of the resting potential of native neuron (-70 
mV). In addition, the depolarization/repolarization phase and hyperpolarization 
phase both lasted approximately 1 millisecond apiece, akin to native nerve cells 
[145].   
While a typical neuronal action potential causes a depolarization to 30-50 
mV, extracellular measurements typically record weaker signals due to the 
dissipation of the strength of the generated electrical field as it travels through the 
medium towards the microelectrode.  Although the measurements were made 
extremely close to the target neurons, the action potentials measured prior to 
amplification were only about 1 mV.  Fortunately, previous literature supports 
these values, as a study of retinal ganglion cells in vitro generated recorded 
potentials in the 1-2 mV range with a similar pulse stimulation setup [146].  While 
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baseline (Phase 2).  Once the signal has returned close enough to baseline, a neuronal action 
potential can be seen (Phase 3). (C) Various recorded motor neuron action potentials are overlaid, 
each from different neural cell clusters in different dishes, demonstrating the overall homogeneity 
of mature motor neuron action potential properties.  Stimulation occurs immediately prior to the 
beginning of the displayed recordings. (D) A side by side comparison of a stimulation-based 
recording of a control dish (mESCs) and experimental motor neuron dish (blue rectangle 
indicates action potential) using the same parameters demonstrates the ways in which the media 
and surrounding cells modulate the instrumentation’s return to baseline.        
2.4 Discussion 
Incorporating RA into the growth medium 24 hours before switching to 
differentiation medium is a critical step for mouse motor neuron induction. During 
ESCs division, one or both daughter cells maintain the stem cell phenotype, and 
it is controlled by both intrinsic and extrinsic mechanisms. Stem cells divide either 
symmetrically or asymmetrically. The growth medium provides different external 
signals that will keep a balance between symmetrical and asymmetrical divisions 
and maintain an appropriate numbers of stem cells. In other words, the 
pluripotent circuitry is not an independent entity, but rather a regulatory system 
which maintains ESCs and chooses which induction pathway to pursue. 
Incorporating RA into the medium breaks this balance and forces more stem 
cells towards ectoderm linage. In addition, comparing to mESCs, RA-treated 
ESCs are less sensitive to the existence of growth factor. Therefore, when the 
LIF is withdrawn from the medium, cells have a higher tolerance to the new 
medium thus preventing them from apoptosis because of the environment 
change. 
The impact of NaB as a metabolite inductive factor was clearly 
demonstrated by the upregulation of neural stem cell markers Nestin and neural 
marker MAP2 as compared to controls that did not receive the NaB treatment 
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(Figure 2.3A).  While the mesoderm factor was significantly downregulated in 
comparison to the expected ectoderm factors, the endoderm factor Sox17 was 
maintained at similar levels in both the treatment and control group.  The 
maintenance of endoderm factors in addition to ectoderm factors prior to motor 
neuron differentiation likely has an evolutionary origin.  The germ layer, the 
primary layer of cells which form during embryogenesis, produce three layers in 
humans (ectoderm, endoderm, mesoderm), however in vertebrates without 
bilateral symmetry only two layers (ectoderm and endoderm) are produced [146].  
It is clear that evolutionarily the ectoderm and endoderm are more tightly related, 
which likely causes the similarity in ectoderm and endoderm markers expression 
levels during the initial induction period towards immature neurons.    
While the use of Noggin is traditionally essential for neural tube 
development or neural cell induction, the impacts of using Noggin alone versus 
using it alongside the three metabolites were investigated here.  Noggin is a non-
metabolite essential signaling molecule that promotes patterning during 
embryonic development, and in the absence of BMP4 it will cause the patterning 
of the neural tube.  This is why BMP inhibitors are essential in this study.  
Examining the results of real time PCR, the most important marker of success is 
the expression of ChAT, which indicates the presence of a mature motor neuron.  
While using Noggin alone generated a 3-fold increase in the expression of ChAT 
by day 7 over controls which did not receive Noggin, the addition of the three 
metabolites generated an expression of ChAT that was almost 24 times as 
strong as the control group (Figure 2.4).  Another strong indicator of the success 
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of this experiment was the expression of HB9, another motor neuron marker.  By 
the 11th day of the protocol, while the Noggin group only had twice the level of 
expression as compared to controls, the combination of all three metabolites was 
expressed almost 30 times as strongly.  It is evident that the metabolite approach 
is significantly quicker for obtaining mature motor neurons by examining the 
interplay between the Olig2 expression, an immature motor neuron marker, and 
ChAT, a mature motor neuron marker.  On day 7 of the experiment, the 
expression of Olig2 was far higher expressed in the N group than in the N+ M 
group, while at the same time the expression of ChAT was significantly greater in 
the N+ M as compared to the N group.  It is evident that the addition of these 
metabolites to the Noggin improves the speed and efficiency by which these cells 
are induced into motor neuron lineage. 
While the efficacy of the metabolite approach has been demonstrated 
through the previous experiments, whether there was any interplay within this 
group of metabolites was considered to determine if there was a possibility that a 
sub-combination of the three metabolites would be more efficient than using 
them all.  After carrying out real time PCR using various combinations, it became 
clear that for the most highly desired marker, the mature motor neuron marker 
ChAT, the combination of all three metabolites was significantly more expressed 
than any sub-combinations or a control group that received no metabolites by 
day 9.  Examining the expression of the motor neuron progenitor, Olig2, there 
was little difference in its expression as compared to controls.   Since this is 
already day 9, this may be an indication that most of the immature motor neurons 
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had already matured by this point.  While the motor neuron marker ISL1 is not as 
much of an indicator of maturity as ChAT, its expression was not significantly 
different between the groups either.  
  One surprising result from this analysis was the unexpected upregulation 
of GFAP, an astrocyte marker, when the specific combination of Genistein and 
NaB was used.  GFAP was expressed 4 times as much with this combination as 
opposed to the combinations of Genistein and NaF or Genistein, NaB and NaF.  
At first glance, this data seems to indicate that the combination of NaB and 
Genistein plays a catalytic role in astrocytic induction, which can be suppressed 
through the addition of NaF.  To examine the potential method of action, a 
commercially available astrocyte differentiation media, Gibco Astrocyte Medium 
(Gibco) was first examined.  A particular component of it added in catalytic 
amounts is called sodium selenite.  Sodium selenite is used in astrocyte 
differentiation media to protect the cells against oxidative stress, a process that 
simultaneously aids in the induction process.  Based on the fact that only the 
combination of Genistein (oxidative stress reducer) and NaB (neural lineage 
differentiation assistor) upregulate the GFAP marker, while NaF (another 
oxidative stress reducer) inhibits the effect, it seems that the origin of these 
results may lie in the mechanisms of action of NaF and Genistein.  While NaF 
works through activation of the Nrf2 antioxidant pathway, Genistein acts through 
the inhibition of protein phosphorylation at tyrosine residues.  While analysis of 
the differences in mechanism of action between these two processes may hold 
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promise in uncovering a metabolite approach to astrocytic induction, further 
studies will be needed to investigate this.                
Real time PCR was used to confirm analytically that there was any 
difference between the expressions of cells cultured in PUR to those in SHH.  
Examining four markers previously described, Olig2, ISL1, HB9 and ChAT, it 
could be seen that there was an insignificant difference between groups in the 
production of mature motor neurons, as measured using ChAT.  The only 
significant difference between the groups was in the expression of the immature 
motor neuron marker Olig2, but since the difference is minute and ChAT was 
comparably expressed it is believed that these molecules are truly 
interchangeable.   
While real time PCR and Immunocytochemistry are valuable molecular 
techniques for characterizing differentiated cells, electrophysiology was essential 
for demonstrating that the mature motor neurons could be electrically stimulated 
and generate typical action potentials.  Fortunately, the resting potential, peak 
voltage and timescale of neuronal action potentials was all shown to mimic native 
tissue.  With the addition of electrophysiological analysis, the mature motor 
neurons have been demonstrated to mimic native tissue functionally, structurally 
and molecularly. 
By choosing metabolites that affect stem cell metabolism in known ways, 
a highly effective protocol was derived.  We have mentioned previously how NaF 
acts as an antioxidant by stimulating the Nrf2 antioxidant pathway, but previous 
literature has shown that the mechanism of this pathway involves the redirection 
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of glucose and glutamine away from glycolytic pathways towards more anabolic 
pathways [147].  Clearly, the actions of NaF induce the differentiation of motor 
neurons from ESCs through this metabolic modification.  The effects of Genistein 
can also be shown to have a metabolic origin.  Genistein is a phytoestrogen, 
belonging to the category of isoflavones, which intrinsically have anthelmintic 
activity that inhibit glycolysis enzymes [148].  Thus it is evident that an origin of 
Genistein’s ability may lie in an underlying metabolic mechanism.  To finalize the 
claims, NaB modulates metabolism must be demonstrated as well.  Fortunately, 
NaB has been shown to modulate glutamine metabolism by decreasing cell’s 
ability to oxidize glucose, shifting the metabolism away from glucose and towards 
the oxidation of butyrate [149].  RA was also an essential component of this 
study, and numerous studies have recognized that it induces a metabolic shift 
from glycolysis towards oxidative phosphorylation [150].  Through these claims, it 
is clear that the array of small metabolites not only has been proven to help with 
cell induction and survival, but also share an underlying metabolic mechanism.               
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CHAPTER 3 Development of Electrospun Fiber Scaffolds using Poly (glycerol-
dodecanedioate)/Gelatin Blended for Neural Tissue Engineering 
3.1 Introduction 
The definition of tissue engineering in simple terms is to fabricate a tissue 
construct mimicking the structural and functional characteristics of native tissues 
in an in vivo environment. One critical success factor of such an endeavor is to 
fabricate a skeleton, also known as ‘scaffold’, to imitate the function of the native 
extracellular matrix (ECM) [151]. ECM in native tissue interacts constantly with 
cells through various mechanical and biochemical means [152]. Therefore, an 
ideal scaffolds must meet several requirements that include biocompatibility, 
mechanical stability, appropriate topography, and presenting proper chemical 
signals.  
Currently, there are three common methods for fabricating nanofiber 
scaffolds:  phase separation, self-assembly, and electrospinning [11]. Among 
these techniques, electrospinning is the most popular due to its versatility, 
flexibility and cost efficiency [153, 154]. The electrospun fibrous scaffolds present 
an array of characteristics found in native ECM including high aspect ratio, high 
specific surface area, and high porosity with small pore size. To date, fibrous 
biomaterials have been generated from collagen [25], gelatin [62], poly(ε-
caprolactone) (PCL) [41], poly(D,L-lactic acid- co- glycolic acid) (PLGA) [15, 16],  
and poly(L-lactic acid) (PLLA) [14] using electrospinning. It is believed that 
electrospun fibrous materials will play a critical role in several tissue engineering 
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areas such as neural, bone, cartilage, skin, tendon, ligament and cardiovascular 
tissue engineering [11].   
Choosing a suitable material to fabricate tissue scaffolds is the first most 
significant step for tissue engineering. Popular biodegradable polymers such as 
poly (lactic acid) (PLA), poly (glycolic acid) (PGA) and their copolymers are 
exceptionally stiff materials. For soft tissue engineering application, 
biodegradable elastic materials are desired in order to better match the 
mechanical properties of soft tissues. Motivated by this need, a biodegradable 
polyester elastomer poly (glycerol-dodecanedioate) (PGD) was developed by 
thermal condensation of glycerol and dodecanedioic acid (DDA) (Figure 2.1) [19]. 
Both glycerol and dodecanedioic acid can be derived from biorenewable sources 
[155, 156] and can be metabolized by human cells as energy sources [157, 158], 
thus both monomers exhibit minimal cytotoxicity.  
 
Figure 3.1. Synthetic biodegradable elastomer, poly (glycerol-dodecanedioate). 
PGD polymers also possess several beneficial characteristics for soft 
tissue engineering applications. Stiffer synthetic materials such as poly (hydroxyl 
butyrate) and poly (L-lactide) have Young’s moduli of 250 MPa and 660 MPa, 
respectively, while the biodegradable polymer PGD displays an elastic property 
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similar to rubber, with a Young’s modulus of 1.08 MPa at temperatures above 37 
˚C, and as such is a close match to the in-situ Young’s moduli of the peripheral 
nerve (0.45 MPa), spinal cord tissue (0.2 MPa-0.8 MPa) and skin (4.2-8.5 MPa) 
[18, 159-162]. Moreover, the mechanical and physical properties of PGD can be 
tuned for different tissue engineering applications by adjusting its chemical 
composition ratio and fabrication processes.  However, like other synthetic 
polymers, PGD does not carry proper chemical signals to promote cell adhesion 
and proliferation. To address this shortcoming, adding gelatin, a denatured form 
of collagen, into a PGD construct is considered.   
Gelatin, which is derived from partial hydrolysis of native collagens in 
animal skin, tendon, cartilage and bone, has been widely used for 
pharmaceuticals, wound dressings and tissue engineering due to its wealth of 
merits including biological origin, biodegradability, biocompatibility, formability 
and low cost [163-165]. However, the strong hydrogen bond interactions in 
gelatin molecules often leads to a three dimensional macromolecular network. As 
a result, the mobility of gelatin chains decreases greatly and makes it difficult to 
be electrospun alone or requires toxic solvent to dissolve [62]. Since PGD can be 
dissolved in most organic solvents and even in a mixture of ethanol and water, it 
is interesting to investigate whether PGD and gelatin can be blended and 
electrospun into fibers to get hybrid scaffolding materials.  
Electrospinning is one of the simplest and most versatile techniques to 
produce micro-to-nanometer size fiber scaffolds from polymers or other 
materials. The basic principle of electrospinning involves a Taylor cone of 
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Figure 3.2.  Electrospinning setup including a syringe pump, a high voltage power supply and a 
new designed collector. 
3.2     Experimental 
3.2.1 Determination of PGD molecular weight by Gel Permeation 
Chromatography (GPC)/Size Exclusion Chromatography (SEC) 
A High Performance Liquid Chromatography (HPLC) system (Perkin 
Elmer, Flexar) equipped with a 25 cm long GPC column (Jordi Gel DVB Column- 
5 μ, 250 x 4.6 mm, Mixed Bed, Jordi Labs) was used to determine the PGD 
molecular weight (MW). The analog outputs from both the UV detector and the 
Evaporative Light Scattering Detector (ELSD) were fed to a data acquisition unit 
(BIOPAC, model MP100) to be converted into digital signals. Then the acquired 
signals were processed, displayed and stored in a computer for later analysis.  
A polystyrene molecular weight standard kit with the MW ranging from 497 
Da to 1.03×106 Da (TSK standard POLYSTYRENE, TOSOH, Japan) was used to 
establish the calibration curve of MW vs. retention time. For sample preparation, 
3 mg of PGD from different time points (24 hours, 72 hours and 96 hours) were 
dissolved in 3 mL of Tetrahydrofuran (THF) in a glass vial. The vial was shaken 
until the polymer has completely dissolved. Then 100 µl sample was loaded into 
the HPLC system with a syringe. Both analog signals of UV and ELSD were 
digitalized at a rate of 200 samples per sec.  This procedure was repeated three 
times for each sample. For data analysis, the data acquired from the BIOPAC 
software were imported into a Microsoft Excel spreadsheet. At each sampled 
time point, the voltage output of the ELSD was used to calculate the 
corresponding MW from the established calibration curve by assuming the 
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voltage output is proportional to the numbers of polymer (created by 12 
polystyrene standards of differing molecular weights) to calculate the log of the 
molecular weight for that sample point. Taking the anti-log of this gave a 
molecular weight measurement that was then multiplied by the voltage reading at 
that sample point. The product of the molecular weight and voltage measurement 
at each of the bounded sampled points, as well as the voltage measurements, 
were then summed. Finally, the summed product of molecular weight and voltage 
was divided by the summed voltages to calculate the number-average molecular 
weight (Mn) using Equation 3.1: 
                                  Mn=
∑ ୑౟୬౟ಮ౟సభ
∑ ୬౟ಮ౟సభ
 = ∑ ୑౟୚౟ಮ౟సభ∑ ୚౟ಮ౟సభ                                                 (3.1) 
where Mi is the ith sampled point’s corresponding molecular weight and Vi is the 
ith sampled point’s voltage measurement. 
By taking the same approach, the following equation was used to 
calculate the weight-average molecular weight (Mw):  
 
                                        Mw=
∑ ୑౟మ୬౟ಮ౟సభ
∑ ୑౟୬౟ಮ౟సభ
= ∑ ୑౟మ୚౟ಮ౟సభ∑ ୑౟୚౟ಮ౟సభ                                             (3.2) 
3.2.2 Preparation of PGD/gelatin polymer solution and fabrication of 
electrospinning fibers 
To prepare the polymeric solution for electrospinning, glycerol and 
Dodecanedioic acid (DDA) from Sigma-Aldrich (St Louis, MO) were mixed in a 
molar ratio of 1:1 and reacted at 120 °C for 100 hours to procure PGD polymers. 
Meanwhile, a mixture of poly(ethylene oxide) (PEO), gelatin, and solvent (65% 
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ethanol and 35% water) with a combination of 1.5 : 3 : 95.5 (w/w), which was 
denominated as the basal solution (BS), was heated in a low temperature oven 
and stirred every 10 minutes until it became a homogeneous solution. PEO with 
a high average molecular weight (600,000 Da), when combined with PGD, 
allowed for synthesis of longer fibers. The testing solutions for making 
electrospun fibers were composed of 50% PGD and 50% BS, 40% PGD and 60% 
BS, 30% PGD and 70% BS, and 20% PGD and 80% BS, respectively. In addition, 
0.1% riboflavin was incorporated into the polymer solution as a photoinitiator for 
later crosslinking process. Then the polymeric solution underwent the 
electrospinning process described in section 2.3. Additionally, in order to 
evaluate the impact of gelatin on fiber forming and cell attachment, polymeric 
solutions without gelatin but containing 20-50% PGD concentration were 
prepared by dissolving in solvent (65% ethanol and 35% water) and adding 2.6% 
(w/w) PEO.   
In the typical experimental procedure, the polymeric solution was fed into 
a 5 ml standard syringe and delivered through an 18G blunted stainless steel 
needle by a syringe pump (Fish scientific, USA) at a flow rate of 0.6 ml/h. 
Electrospun fibers were fabricated in an operating voltage of 14.6 kV (SL30, 
Spellman High Voltage Electronics Corporation, USA), and the distance between 
the needle tip and the ground collector was 25 cm. An aluminum foil strip was 
attached perpendicular to a flat metal plate as the electrospinning collector, and 
fibers formed across the gap between this strip and the plate. In order to get a 
more uniform fiber mat, the syringe pump was placed at an angle of about 15 
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degrees with the horizontal to prevent aggregation of fibers at the front of the 
strip. After electrospinning, the fibers were exposed to UV light for around 80 
minutes to enhance the crosslinking process.  
3.2.3 Characterization of PGD/gelatin fiber scaffolds 
3.2.3.1 Scanning electron microscopy (SEM) of Electrospun fibers 
The electrospun fibers of PGD with and without gelatin were analyzed 
using scanning electron microscopy (SEM, JEOL JSM6330F, Tokyo, Japan) at 
various magnifications. Before imaging, the fiber samples were placed in a gold 
sputter coater for 2 minutes to deposit a thin conductive film. The average 
diameters of the fibers were determined by means of Image J 1.47v software at 
100 different locations of the SEM images.  
3.2.3.2 Raman spectroscopy 
Raman spectra were taken with Raman Micro 400 Series Raman 
Spectroscopy (Perkin Elmer) using a 50X objective lens and with a 2-second 
exposure time. These spectrum data were used to evaluate the polymerization 
process and the chemical structures of PGD, gelatin and their mixture pre- and 
post-electrospinning. The samples were taped to the shiny side of an aluminum 
foil covering the microscope slides [167]. 
3.2.3.3 Dissolvability test                      
Fiber samples, which had already been exposed to UV light for 80 minutes, 
were cut into small round pieces of the same size and placed into 60-mm culture 
dishes. Two milliliters of the Phosphate Buffered Saline (PBS) were added to 
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each plate and the plates were kept at 37 °C for one month to test the 
dissolvability of the cross-linked scaffolds. 
3.2.4 In vitro studies of PGD/gelatin fibers with human foreskin fibroblasts 
3.2.4.1 Cell seeding 
Human Foreskin Fibroblasts (HFF) cells acquired from Globstem 
(Rockville, Maryland) were used to test cell viability on the PGD fiber scaffolds 
with and without gelatin. These cells were cultured in a medium that consisted of 
90% DMEM/F12 basal medium (Thermo Scientific), 1x antibiotics/antimycotics 
and 10% fetal bovine serum (FBS) (Sigma-Aldrich, St Louis, MO). Fiber samples 
made from different compositions were cut into small round pieces of the same 
size and placed into a 6-well plate with low cell binding surface (Nunc, Fisher 
Scientific). For pre-seeding treatment, specimens were soaked in PBS for 3 
hours and subsequently immersed in fresh medium and kept at 37 °C overnight. 
Before seeding, cells were counted using a hemocytometer and then seeded to 
the scaffolds at a 5.0×104 cells/well density. Following the addition of the cell 
suspension droplet, the fiber mats were kept in an incubator at 37 °C and 5% 
CO2 to allow cell attachment.  
3.2.4.2 Visualization of cells on the fibers 
In order to visualize cells on the fiber scaffolds, Calcein AM, a cell-
permeant dye purchased from Invitrogen (Grand Island, NY) was used to stain 
the live HFF cells. After culturing the cells at 5.0 ×104 cells/well density for 1 day, 
1 µl of the Calcein AM reagent was added into 2 ml of cell culture medium and 
incubated for one hour. Thereafter, the fluorescence signal from the cells was 
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visualized under the confocal microscope (D-Eclipse C1, Nikon) by using an 
excitation wavelength of 488 nm. 
3.2.4.3 Evaluation of cellular viability 
Resazurin fluorescence dye (Sigma-Aldrich, St Louis, MO), which had 
been shown to be identical to the commercial assay Alamar Blue [141], was used 
as an index of cellular viability [168]. After 24 hours cell culturing on the scaffold, 
the culture medium was drained and 100 µl of the reagent were added to each 
well, mixed with 2 ml of fresh medium. Background controls of 2 ml of medium 
plus 100 µl of the resazurin reagent were also performed. The plate was placed 
in an incubator at 37 °C and 5% CO2 for 4 hours to allow the cells to metabolize 
the resazurin. Then 100 µl medium samples of the different composition of fiber 
mats as well as the control group (sample numbers in each group, n=4; 
experiment was repeated 3 times), were collected into a 96-well plate in triplicate. 
Thereafter, the 96-well plate reader was set to measure the fluorescence 
intensity of a 590 nm emission with an excitation wavelength of 530 nm. The 
same procedure was repeated at different time points (1 day, 3 days, 5 days and 
8 days). Subsequently, the data of fluorescent intensity were converted to cell 
numbers according to the established standard curve (known cells number v.s. 
fluorescent intensity), and used to compare the number of metabolically active 
cells in different samples. 
3.2.5 Statistics     
Analysis of variance (ANOVA) and Turkey’s HSD tests were used to 
evaluate the significance between the PGD with gelatin fibers, PGD without 
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gelatin fibers and control group (n = 4) for cell viability testing. Kruskal-Wallis 
Test and Mann–Whitney U-test were performed to determine the statistical 
difference between groups in fiber diameter distribution. In both cases, the 
statistical significance was set at p < 0.05. 
3.3     Results 
3.3.1 Characterization of PGD polymer 
3.3.1.1 Determination of PGD molecular weight 
An HPLC system combined with a GPC/SEC column is the most 
convenient method to measure the MW of polymers and their MW distributions. 
In this study, two detectors (UV and ELSD) were used to monitor the elution of 
polymers. It was found that PGD polymers were almost invisible in the UV 
detector. Therefore, detection of the elution time for PGD polymers was 
performed by ELSD. The determined number/weight average molecular weights 
of PGD at 24 hours, 72 hours and 96 hours are shown in figure 2.3, which were 
in the order correlated to its overall reaction time. Table 3.1. shows the different 
Mw and Mn of PGD and the polydispersity index, Mw /Mn. The larger the index, the 
wider the polymer molecular weight distribution is [169].  
Table 3.1. Number- and Weight- average molecular weight and the polydispersity 
index of PGD on different time points. 
 Number-Average 
Molecular Weight 
(Mn) 
Weight-Average 
Molecular Weight 
(Mw) 
Polydispersity 
index 
PGD 24 hours 1354 2184 1.61249 
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Figure 3.4. Raman spectra of DDA, glycerol and PGD, respectively 
3.3.2 Characterization of PGD/gelatin electrospun fibers 
3.3.2.1 The newly designed collector and the effects of PGD concentration on 
fiber size 
By adopting our newly developed electrospinning collector, PGD was 
dissolved in 65% ethanol/ 35% water and electrospun from the solution 
containing 20%-50 %( w/w) PGD, and the fibers were deposited between the 
aluminum foil strip and the aluminum plate (Figure 3.5). From figure 3.5A, it is 
clear that the fibers were spanning between the strip and the plate, thus the fiber 
mats could be easily harvested without the risk of damaging to the fibers. In 
contrast, when using a traditional collector, i.e. a flat metal plate, the fibers 
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attached strongly to the collector surface, and it was unable to easily harvest an 
intact fiber mat. In addition, the aluminum foil strip could be adjusted to fabricate 
different sizes of fiber mats. For example, the fiber mat could be easily obtained 
in the size of 9 cm by 15 cm as shown in figure 3.5B and 3.5C.  
Incorporating 2-3% (w/w) gelatin into the polymeric solution with 20-50% 
(w/w) PGD was also investigated and found that PGD blended with gelatin can 
be also electrospun into fibers. Another important observation was that a small 
amount (1-2%) of the high molecular weight PEO would result in better long fiber 
obtainment, therefore PEO was used in all studies. Furthermore, fibrous 
scaffolds were examined by using SEM to determine the diameters and 
morphologies of the fibers. One hundred randomly selected areas were chosen 
from the SEM images shown in figure 3.6 to calculate the average diameters of 
the fibers in each group. As shown in figure 3.6, the fibers produced from 30% 
(w/w) PGD solution had the smallest diameters, with a mean diameter of 
0.95±0.91 μm. It is observed that when using higher PGD concentration, 
increased fiber diameters are acquired with mean diameters of 3.33±1.71 and 
4.93±7.28 μm. The results also showed that the polymeric solution with 20% 
PGD polymer was not able to produce electrospun fibers. This result indicated 
that PGD concentration has a significant effect on the electrospun fiber diameter. 
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Figure 3.7. Raman spectra of PGD/BS fibers prior to and after electrospinning. 
3.3.2.3 Fiber dissolvability 
Dissolvability testing of the PGD with gelatin scaffolds was performed to 
study the stability of the fibers in PBS at 37 °C for four weeks. The fibers without 
crosslinking dissolved in PBS quickly (data not shown). In order to increase its 
stability, riboflavin, which is a photo initiator, was incorporated into the polymeric 
solution before electrospinning. Since ultraviolet (UV) light was used to sterilize 
the fibers, it is worth of investigating whether UV light could be, simultaneously, 
used for sterilization and crosslinking. After being exposed to UV light for 80 
minutes, the fiber scaffolds maintained its structural integrity in PBS for a one 
month. Figure 3.8 shows the change in morphology and structure of the PGD 
with gelatin fibers during the degradation process. Compared to figure 3.6, the 
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morphology of some of the fibers changed after 4 days (Figure 3.8A) and this 
change became more obvious after two weeks, which is reflected by the fact that 
fibers were swelling and fused together (Figure 3.8B). On day 28, under higher 
magnification, even though some fibers were broken down into short pieces, the 
fiber structure was mostly preserved (Figure 3.8C).  
 
Figure 3.8. Surface morphology of the degraded PGD with gelatin fibers after different time points. 
PGD with gelatin fibers after (A) 4 days; (B) 14 days and (C) 28 days. 
3.3.3 In vitro studies of PGD/gelatin fiber scaffolds  
3.3.3.1 Visualization of cells on fiber scaffolds 
Calcein AM, a cell-permeant dye, was used to visualize the live cells in 
PGD fibrous scaffolds. In live cells, the nonfluorescent calcein AM is converted to 
a green-fluorescent calcein after acetoxymethyl ester hydrolysis by intracellular 
esterases. After 1 day of cultivation of HFFs on fiber scaffolds in a 6-well low 
adherent plate as well as cultivation of the control group cells on the 35 mm 
tissue culture dish without fibers, Calcein AM dye was added and confocal 
microscopy was used to acquire the fluorescent images. The cell morphology on 
the two surfaces was considerably different. On the fiber scaffold, most cells 
attached to the fibers exhibited round shapes with less spreading, although a 
small fraction of cells developed multi-cell clusters (Figure 3.9A). In contrast, on 
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certain minimum requirements for biochemical and physical properties, namely, 
mechanical stability, biocompatibility, and topography. 
PGD is a biodegradable elastomeric polymer synthesized from glycerol 
and DDA. It is biocompatible, exhibits elastic behavior and unique shape memory 
[19]. The Mn and Mw of PGD after 4 days are approximately 20 and 111 kDa, 
respectively. The fibrous scaffolds made from PGD provide a good solution for 
soft tissue engineering because their elastic properties better match the 
mechanical properties of soft tissues when compared to other stiffer synthetic 
polymers. The properties of the electrospun fiber are greatly influenced by 
several processes and solution parameters. The composition of the polymeric 
solution is extremely important for achieving ideal fiber scaffolds. PGD 
concentration ranging from 30% to 50% (w/w) with and without gelatin can 
generally produce the desired fiber mats. Increasing PGD concentration raises 
the viscosity of the polymer solution resulting in fibers with larger diameter size 
as well as a smaller porous structure. Although decreasing the PGD 
concentration will lessen the diameter of the fiber, there is a greater chance of 
having drops on the fiber mat.   
With other synthetic polymers like PLGA and PCL for electrospinning 
PLGA/Gelatin/Elastin [172] and PCL/Gelatin fibers, more expensive and toxic 
solvents such as hexafluoro-2-proponol and trifluoroethanol are required to 
dissolve gelatin, elastin and polymers. In contrast, PGD can be easily dissolved 
in solvents like a mixture of ethanol and water, thus incorporation of water-
soluble biomolecules such as gelatin into PGD in our study became a 
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straightforward job. The advantages of using a less toxic solvent like ethanol 
include fabrication flexibility and minimizing the safety concern. 
Furthermore, it is also interesting to monitor the chemical structure 
changes during the PGD polymerization and electrospinning fabrication. DDA is 
a molecule with carboxylic groups at both ends, and glycerol has three free 
hydroxyl groups. During the polymerization process, these two functional groups 
react to form a new ester bond after removing one water molecule. Glycerol with 
three hydroxyl groups allows the polymer to form branch structures and results in 
a three dimensional network after curing. The C=O stretch, which appears at 
1730-1740 cm-1 on raman spectra, was an indication of ester bonds and was 
present in the PGD polymer, PGD/Gelatin blend and the final electrospun fibers. 
The similarities in the Raman spectra of pre- and post-electrospun polymers 
demonstrated that the electrospinning process did not change the chemical 
structure of the polymer. 
Crosslinking of electrospun fibers is carried out in an attempt to preserve 
the scaffold fibrous architecture. The fiber scaffolds before crosslinking dissolved 
quickly in PBS at 37 °C (Data not shown). Therefore, it is essential to stabilize 
the scaffold by using a crosslinking agent, which would preferably be nontoxic to 
the cells. Riboflavin, before known as vitamin B2 or additive E101, is an easily 
absorbed micronutrient with a key role in maintaining health in humans and 
animals [173]. According to the previous study, it also acts as a photo initiator to 
crosslink collagen with the help of short UV exposure for eye treatment [174, 
175]. In this study, 0.1% riboflavin was incorporated into the polymer solution 
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before electrospinning, and after the fiber mat was collected, it was exposed to 
UV light for around 80 minutes. Compared to the scaffold, which was not 
crosslinked, the crosslinked fiber mat could grossly maintain its structural 
integrity in PBS at 37 °C for up to 28 days. 
The continuous increase in cell numbers on the PGD with gelatin fiber 
scaffolds over a period of 8 days indicated that cell proliferation took place on 
these fiber mats, similar to the traditional 2 dimensional culture dish. In contrast, 
cells on the PGD without gelatin fibers exhibited relatively slower proliferation. 
This suggests that the natural polymer gelatin plays a key role in cell adhesion 
and proliferation. Both PGD and PEO are synthetic polymers; hence there are no 
binding sites for cells to attach to. Gelatin derived from collagen provides sites 
(ligands) for cell adhesion thus improving cell proliferation. Therefore, PGD 
blended with gelatin also exhibits similar properties for promoting cell adhesion 
and proliferation, which in turn enhances the fiber mat biocompatibility.  
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CHAPTER 4 Modification of Electrospun Fiber Scaffolds Composed of PGDF for 
Neural Tissue Engineering. 
4.1 Introduction 
Biomaterials play a vital role in tissue engineering because it is the key 
ingredient of the scaffolds created to facilitate cell attachment, proliferation, 
differentiation, and, ultimately, new tissue formation.  Many techniques have 
been developed for 3D scaffolds fabrication over the past 20 years. Recently, 
micro/nanofiber-based scaffolds produced via the electrospinning technique are 
gaining increasing interests since it offers the opportunity for control over the 
composition of the fibers along with porosity of the fiber meshes using a relatively 
simple experimental setup. Structurewise, electrospun fiber scaffolds bear a 
strong resemblance to the hierarchical structure of the extracellular matrix (ECM), 
an environment critical for cell survival, differentiation, signal transduction and 
nutrient/waste transport [13]. Furthermore, electrospun fibers can be modified 
using different physical or chemical methods to encapsulate or attach bioactive 
molecules such as native ECM proteins or RGD peptides to support and guide 
both the survival and differentiation of cells seeded on the scaffold. All these 
attributes make electrospun fibers a new class of promising scaffolds for neural 
tissue engineering. 
4.1.1 Embedding Biomolecules into fiber Scaffolds for Neural Tissue 
Regeneration 
While scaffold-based approaches have been utilized in the past to support 
the repair of neural tissue, a fundamental limitation of these strategies is the lack 
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of appropriate biomolecules embedded in the scaffold.  Without the presence of 
these biomolecules, continuous delivery requires a stream of complex surgical 
procedures to inject them into the site of injury [176].  Unfortunately, this does not 
ensure that the concentrations of these biomolecules remains constant over the 
duration of release.        
Ever since the development of polymer-based implantable therapies, 
scientists have worked hard to learn how to further functionalize these surfaces 
in order to create specialized cell surface interactions.  Two fundamental 
methods exist for coating polymers – using proteins and using peptides [177].  
Adhesive proteins such as fibronectin, collagen and laminin were initially 
considered and tested, but they are often purified from other organisms and 
hence may create an immune response.  In addition, due to their large size, it is 
not certain if their orientation at any particular moment will be suitable for cell 
adhesion.  Finally, they are potential targets of proteolytic degradation; therefore, 
their concentration will not be constant over time.  On the other hand, peptides 
have emerged as a superior option due to their enhanced stability and higher 
potential packing density.  While protein-based options originating as ECM 
components have the potential to activate a variety of cell recognition motifs due 
to their size, peptides are far more selective and can activate single motifs.  
Therefore the RGD-sequence and laminin were chosen as the biomolecular 
peptides of this study.  
4.1.2 Functions of poly (glycerol- dodecanedioate co-fumarate) 
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PGDF is a novel polymer derived from previously researched polymer 
PGD [143]. PGD was chosen as a base for the polymer since its mechanical 
properties are suitable for soft tissue engineering. PGD is advantageous since its 
synthesis is simple, non-toxic and has good biocompatibility. In addition, the 
diameter of derived fibers can be adjusted easily by changing the concentration 
of PGD. 
One disadvantage of the PGD polymer is that it is composed of saturated 
polyester chains that only have hydroxyl or carboxylic groups available for 
chemical modification. If another double-bond containing monomer is introduced, 
the resulting polymers with unsaturated polyester chains may provide new 
modification possibilities. These properties, in turn, can be used to modify PGD 
fibers and facilitate cell attachments. For this reason, Fumaric acid, a non-toxic, 
naturally occurring monomer, was incorporated into the PGD polymer synthesis 
process and produced a PGD derivative referred as poly (glycerol 
dodecanedioate co-fumarate) (PGDF). Fumaric acid has also been demonstrated 
to be both neuroprotective and cardioprotective through activation of the Nrf2 
antioxidant pathway [127, 128].  Sodium Fumarate (NaF) is derived from Fumaric 
Acid, which is a metabolite and intermediate product of the citric acid cycle [129].  
Time-dependent and concentration-dependent studies have been carried out that 
demonstrate NaF to be immunomodulatory and able to reduce oxidative stress 
without altering fundamental network activity.  In vitro, its addition has been 
shown to improve neuronal survival [178]. In vivo, fumarate works to better 
preserve the integrity of myelin, axons and neurons.  The choice to add it to the 
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experimental protocol was due to a fundamental belief that its preservative ability 
would impact cell survival and induction efficiency. 
4.1.3 Peptides modification on the synthetic polymers 
The use of synthetic polymers modified with peptides containing RGD (the 
cell recognition motif) not only triggers cell adhesion but can be used to 
selectively modify the activity of certain cell lines [177].  The RGD peptide 
sequence is useful for stimulating adhesion through the activation of integrin-
family cell adhesion receptors. Integrins are not only used for physical anchoring 
but also promote signal transduction through the membrane of the cell.     
 Laminin was chosen as a biomolecule to integrate into the scaffold since it 
is a naturally occurring ECM protein that promotes the formation of neurites [179].  
It provides a local environment that mimics neural tissue and can be added using 
covalent binding or physical adsorption.  Laminin is continuously synthesized 
after nerve injury and plays essential roles in cell migration, differentiation and 
the growth and elongation of axons.  Myelinating phenotypes of Schwann cells 
cannot occur without the presence of laminin.  Laminin has been used previously 
in electrospinning, for example, incorporated into electrospun poly(L-lactic acid)-
co-poly(e-caprolactone) (PLCL) [180].  This research is the first documented use 
of laminin on the electrospun PGDF scaffold and based on the properties of 
laminin there is a reason to believe this choice is essential to ensure neural 
growth and survival.   
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4.2    Experimental 
4.2.1 PGDF fiber design and fabrication 
PGDF polymer was made from glycerol, DDA and Fumaric acid (FA) (St 
Louis, MO) (Figure 4.1A). To begin with, glycerol and DDA were mixed in beaker 
1 in a molar ratio of 0.6:0:2 and glycerol plus FA in beaker 2 in a molar ratio of 
0.4:0.8. These two beakers were kept at 120 °C for 72 hours until both the acids 
have been completely reacted with glycerol. Then the pre-polymers in both 
beakers were mixed together and kept at the same temperature for another 24 
hours to procure PGDF polymer. For basal solution (BS) preparation, a mixture 
of poly (ethylene oxide) (PEO), gelatin, and solvent (65% ethanol and 35% water) 
with a combination of 1.5 : 3 : 95.5 (w/w), was heated in a low temperature oven 
(around 65°C) with stirring every 10 minutes until it became a homogeneous 
solution. The testing solutions for fabricating electrospun fibers were composed 
of 60% polymer (PGDF:PGD=5:5) and 40% BS, 50% polymer and 50% BS, 40% 
polymer and 60% BS, and 30% polymer and 70% BS, respectively.  In addition, 
0.1% riboflavin was incorporated into the polymer solution as a photoinitiator for 
later crosslinking and peptides immobilization process. These polymeric solution 
were then underwent the electrospinning process. 
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4.2.2 Characterization of PGDF fiber scaffolds 
4.2.2.1 SEM 
The electrospun fibers of PGDF in different concentration were analyzed 
using Scanning Electron Microscopy (SEM, JEOL JSM6330F, Tokyo, Japan) at 
various magnifications. Before imaging, the fiber samples were placed in an Auto 
sputter coater (PELCO SC-7) for 50 sec to deposit a thin Au conductive film. The 
average diameters of the fibers were determined by means of Image J 1.47v 
software at 100 different locations of the 500X SEM images. 
4.2.2.2 Dissolvability test  
After 2 hours UV exposures, electrospun fiber mats were cut into round 
pieces of the same size and placed into 24-well plate for dissolvability test. One 
milliliters of the Phosphate Buffered Saline (PBS) were added to each well and 
the plate was kept at 37 °C for up to 2 month to test the dissolvability of the 
scaffolds. 
4.2.2.3 FA Release Behaviors of Electrospun fiber 
The electrospun fiber mats were sectioned into round pieces and each 
sample was incubated into 10 mL of PBS at 37 °C. Samples of 1 mL released 
solution were taken from the incubation solution at 3 h, 24 h, 72 h, 96 h, 150 h, 
168 h, 192 h, 216 h, 240 h, 264 h, 336 h and 360 h after incubation, while an 
equal amount of fresh PBS was added back to the dissolution medium. The 
amount of FA was detected with a UV spectrophotometer (Synergy HT, BioTek) 
at a maximal absorption peak of 230 nm. For standard samples with a 
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concentration from 15 μM to 1000 μM was determined between the absorption 
strength and FA concentration. 
4.2.2.4 Raman spectroscopy 
Raman spectra were taken with Raman Micro 400 Series Raman 
Spectroscopy (Perkin Elmer) using a 50X objective lens and with a 2-second 
exposure time. These spectrum data were used to evaluate the polymerization 
process and the chemical structures of PGD and PGDF. The samples were 
taped to the shiny side of an aluminum foil covering the microscope slides[167]. 
4.2.2.5 Peptides Immobilization 
The fiber mats were first cut into round pieces and placed into 24-well 
plate. They were then incubated with RGDC peptides or Laminin peptides or 
PBS as a control and exposed to blue light for 3 hours. Thereafter, the samples 
were kept in incubator at 37 °C for another hour and then washed with PBS twice 
to get rid of the unbonded peptides. Fiber samples treated in different groups 
were dissolved in 95% ethanol. Then the dissolution medium were transferred to 
UV-Cuvette (BRAND, Sigma-Aldrich) and read with UV spectrophotometer.  
4.2.3 In vitro studies of PGDF fibers with mouse embryonic stem cells 
4.2.3.1 Cell seeding and distribution 
Fiber samples made from different PGDF concentration were cut into 
small round pieces of the same size and placed into a 24-well. For pre-seeding 
treatment, specimens were soaked in peptides or PBS (as control) for 3 h under 
blue light and subsequently immersed in fresh medium and kept at 37 °C 
overnight. Before seeding, cells were counted using a hemocytometer and then 
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seeded to the scaffolds at a 5.0×104 cells/well density. Following the addition of 
the cell suspension droplet, the fiber mats were kept in an incubator at 37 °C and 
5% CO2 to allow cell attachment. 
4.2.3.2 Cell attachment and survival  
Resazurin fluorescence dye (Sigma-Aldrich, St Louis, MO), which had 
been shown to be identical to the commercial assay Alamar Blue [141], were 
applied as an index of cellular viability [168]. The resazurin reagent was mixed 
with fresh medium in 1:10 (v/v) and added to each well. Cell culture plate was 
kept in an incubator at 37 °C and 5% CO2 for 4 h to allow the cells to metabolize 
the resazurin. Then 100 µl resazurin/medium mixture of different well were 
collected into a 96-well plate in triplicate. Then the 96-well plate reader was set to 
measure the fluorescence intensity of a 590 nm emission with an excitation 
wavelength of 530 nm. The same procedure was repeated at different time points 
(day4, day6, day8 and day11).  
4.2.3.3 Phenotype expression 
Phenotype expression of the cells on PGDF fiber was examined through 
real-time PCR. Total RNA was prepared from fiber cell culture sample on Day 11 
using SV Total RNA Isolation System (Promega). Each mRNA preparations was 
reverse transcribed into cDNA using olig(dT)15, as described by the manufacturer 
(GoScript Reverse Transcription System, Promega). Real-time PCR was 
performed on a Real Time PCR System (Applied Biosystems). For amplification, 
the cycling parameters consist of 1 cycle at 95 ˚C for 2 min and 20 s, followed by 
40 cycles of 95 ˚C for 3 s and 60 ˚C for 1 min. The comparative CT method was 
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utilized to calculate the relative expression of each target gene, and each is 
normalized relative to the house keeping gene expression of glyceraldehydes-3-
phosphate dehydrogenase (GAPDH) mRNA. 
4.2.3.4. Statistics  
Kruskal-Wallis Test and Mann–Whitney U-test were performed to 
determine the statistical difference between groups in fiber diameter distribution. 
In both cases, the statistical significance was set at p < 0.01. Analysis of variance 
(ANOVA) and Turkey’s HSD tests were used to evaluate the significance 
between the PGDF-RGDC, PGDF-Laminin and PGDF group (Sample number in 
each group: n = 3, experiment was repeated 3 times) for peptides binding and 
cell viability testing. 
4.3 Results 
4.3.1 Characterization of PGDF electrospun fibers 
4.3.1.1 Fabrication of scaffolds with different fiber diameter 
Electrospun fiber scaffolds were examined by using SEM to determine the 
morphology and diameter of the fibers.  By varying the concentration of PGDF 
(30%, 40%, 50%, 60%), electrospun fibers of various diameters could be 
generated (Figure 4.2 A-D). A histogram of the fiber diameters for each polymer 
concentration was conducted to examine the fiber diameter distribution (Figure 
4.2 E-H).  Diameters were measured using SEM pictures and 100 randomly 
selected areas were averaged.  A significant difference was seen in the mean 
fiber diameter of 30% (1.756 ± 0.813 µm), 40% (2.597 ± 0.765 µm), 50% (3.697 
± 0.807 µm) and 60% (4.925 ± 2.148 µm).  It is evident that the spread of fiber 
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4.3.2 Effect of peptides immobilized fibers on cell viability  
4.3.2.1 UV detection of peptides binding 
Using UV spectroscopy, it is simple to detect the presence of the double 
bond in FA.  Since the RGDC and laminin peptides break this double bond when 
bound to the polymer, there should be a significant difference in the double bond 
concentration with and without the peptides (Figure 4.6).  To determine the µM 
concentration of double bond from the absorbance value of the 
spectrophotometer, a standardized curve was developed using different 
concentrations of FA.  As a control, the fiber was incubated with PBS alone as 
compared to the experimental groups where it was incubated with the RGDC and 
Laminin peptides.  In the control group, regardless of the polymer concentration, 
a higher concentration of the double bond FA was detected and expected since it 
would be retained, instead of being broken to bind the peptides as in the two 
experimental groups.       
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examined based upon the different diameter of the fiber (Figure 4.8A) and the 
presence of 2 peptide groups on day 11 (Figure 4.8 B, C).  In addition, PGD was 
examined using real time PCR as an additional control to assess the effects of 
FA on motor neuron differentiation (Figures 4.8B, C). Although many of the 
markers did not express differently between the experimental groups, the 40% 
PGDF polymer was chosen for further study due to the clear upregulation of HB9 
and downregulation of GFAP compared to the alternative concentrations of 
PGDF.  Figures 4.8B and 4.8C examine the 40% PGDF in detail amongst 
different modification of development. For ease of observation, Figure 4.8B was 
split into each experimental group and displayed it in Figure 4.8C. Figure 4.8C 
demonstrates the expression of the markers normalized to their expression in 
PGD.  Since all of the markers in Figure 4.8C are expressed at a value greater 
than one, this indicates that the cells on the PGDF fiber significantly overexpress 
these markers as compared to a PGD control. It is clear that expression of Nestin, 
HB9 and ChAT was not significantly different between the two peptides but was 
significantly overexpressed as compared to PGDF.  MAP2 and Olig2 were 
significantly more expressed in the Laminin group than in the RGDC or PGDF 
group.  Surprisingly, ISL1 was higher expressed in the PGDF group than in either 
of the peptide groups.  Examining the expression of GFAP there was no 
significant difference between any of these three groups.  
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4.4 Discussion  
Tissue engineering has emerged as an excellent strategy for developing 
protocols to maximize neural regeneration in the peripheral nervous system.  
Since cells cannot simply be introduced into the injury site on their own, a 
supportive scaffold has become a necessary part of this technique.  While a 
scaffold may be effective for mimicking the physical, mechanical and 
topographical properties of the cells, the presence of bioactive materials is 
essential to provide continuing support to the implanted cells throughout the 
duration of the repair process.  
 PGDF was chosen for this study since PGD has been demonstrated to 
have sufficient biocompatibility, elasticity and the unique characteristic of shape 
memory[143].  The addition of FA simply made the scaffold more amenable to 
neural lineage survival due to its combination of neuroprotective effects and was 
also crucial since the double bond in its chemical structure could be simply 
broken to attach peptides of choice.  RGDC peptides were more efficient at 
breaking the double bond than Laminin but only at a 50% and 60% PGDF 
concentration.  The composition of the polymer was essential for devising the 
ideal scaffold, and increases in its concentration caused a resultant increase in 
viscosity, leading to a larger fiber diameter.  Previous research has demonstrated 
an effect of fiber diameter and thus this was a factor that was chosen to be 
modified in the experimental design of this study [181]. 
PGDF can be easily dissolved in a mixture of ethanol and water.  In 
contrast, other synthetic polymers such as PLGA and PCL require more toxic 
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and expensive solvents such as hexafluoro-2-proponol and trifluoroethanol [182].  
Using this more straightforward dissolution method ensured that the fabrication of 
fiber mats would not be a safety concern in the final implantation.  This property 
also simplifying the monitoring of the release of FA into the surrounding structure 
over time via UV spectrophotometry.   
In order to investigate the structural changes during polymer formation 
and peptide binding, a combination of Raman spectroscopy and UV 
spectrophotometry was used to check the presence of the internal structural 
bonds.  DDA and FA contain carboxylic groups at both ends and glycerol has 
three free hydroxyl groups, all of which can be easily visualized in Raman 
spectra.  When polymerized, the formation of a new ester bond alongside the 
removal of a water molecule allows the polymer to form branch structures in a 
three dimensional network following the curing process. After peptides binding, 
the decreased double bond concentration indicated that both RGDC and Laminin 
peptides were attached to the fibers by breaking the double bond via Michael 
addition.    
To ensure that the polymer scaffold was effective for maintaining cell 
survival, cell viability was tested using a Resazurin assay.  Mouse ESCs 
differentiated into neural cell lineages due to the presence of FA on the fiber 
alongside the RGDC and Laminin peptides.  Both of the peptides group exhibited 
similar cell viability during the whole differentiation process. On the contrary, 
PGDF fiber scaffolds itself showed over twice difference than the other two 
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groups. The confocal microscopy images also proved the importance of the 
peptides binding on the scaffold regarding with cell viability.  
When examining the results of real time PCR the findings were intriguing.  
All of the following results were collected and normalized to PGD expression and 
each of the experimental groups demonstrated far higher expression than PGD 
control.  These results indicated that the addition of FA alone was already a 
significant improvement for inducing neural lineage differentiation.  Within the 
experimental groups, the expression of motor neuron marker HB9 and mature 
motor neuron marker ChAT were upregulated by the presence of the peptides 
over the PGDF alone.  In addition, the neural stem cell marker Nestin was also 
upregulated in both peptide groups over the PGDF alone.  Laminin was far more 
effective at upregulating the neuron marker MAP2 and the motor neuron 
precursor Olig2 than the RGDC or PGDF groups, which were not significantly 
different.  Laminin is more frequently described as a differentiation factor than 
RGDC, which is more commonly believed to be an attachment factor, and thus 
these results are expected.  The most surprising result was in the expression of 
the motor neuron marker ISL1, where PGDF was found to express it significantly 
higher than in either of the peptide groups.  Previous research utilizing PDL and 
PSHU polymers has indicated that a Laminin coating more effectively 
upregulates ISL1 expression than an RGD coating, but it is unclear why the 
PGDF alone produces higher expression than both of these groups   
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CHAPTER 5 Conclusions and Future Work 
Nerve regeneration is complicated and presents great challenges to 
researchers. Tissue engineering provides an alternate strategy for nerve injuries. 
This dissertation demonstrates a highly efficient motor neuron differentiation 
protocol and a promising fiber scaffold for neural tissue engineering.  
Chapter 2 addresses a highly efficient (65% of cells were HB9+ and 50% 
of cells were ChAT+) and cost-effective method of generating mouse motor 
neurons using metabolites comparing to the existing protocol (See Table 5.1). By 
testing the efficiency of these small molecules as compared to traditional 
approaches, we have begun to uncover the mechanisms by which oxidative 
stress reduction and HDAC inhibition interplay to induce motor neuron 
differentiation. These mechanisms have also been demonstrated to share an 
underlying component – the down-regulation of glycolysis pathways – that hints 
at a fundamental metabolic mechanism that can be used to derive novel 
protocols for any stem cell differentiation approach. Using structural, molecular 
and functional characterization techniques, the merits of this method this verified 
and explored the impact of different molecular pathways, engaged through 
metabolite introduction, on the expression of transcriptional factors, enzymes and 
cytosolic markers. 
Chapter 3 addresses the scaffold fabrication. PGD fiber scaffolds were 
successfully produced by the electrospinning process and fiber diameter was 
controllable through adjusting PGD concentration. The newly designed collector 
allows us to easily obtain fibers with adequate length and integrity. Incorporating 
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riboflavin into PGD/Gelatin fibers to promote the crosslinking process under UV 
light was shown to improve fiber stability. The utilization of a solvent like ethanol 
and water for electrospinning of PGD fibrous scaffolds provides a potentially less 
toxic and more biocompatible fabrication method. Moreover, cell viability testing 
demonstrated that the addition of gelatin leads to significant improvement of cell 
proliferation on the scaffolds.  
In Chapter 4, it is demonstrated that a novel PGDF scaffold modified with 
RGDC and laminin peptides is beneficial for ensuring neural cell viability and 
motor neuron differentiation. The natural release of FA into surrounding areas 
was quantified to understand the bioreactivity of the derived scaffold. In 
combination with UV crosslinking, the developed fiber mats will be able to 
withstand degradation processes long enough for neural tissue engineering 
applications to be viable. Cell viability and cell differentiation were demonstrated 
to be significantly improved with the addition of FA, RGDC and laminin. In sum, 
the combination of PGDF electrospun fiber scaffold and peptide immobilization 
demonstrates a novel approach that provides a low-cost non-toxic methodology 
for peripheral nervous system repair.           
In future study, the new approach of using metabolites for motor neuron 
differentiation will be further tested with other cell types such as hESCs and 
iPSCs. Based on the results of mESCs and previous publications, these three 
metabolites should have similar effects on different pluripotent cell types with 
varied concentration and timing. The performance of these cells combined with 
fiber scaffolds will be evaluated, in vitro and in vivo. We have demonstrated two 
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different peptides that contributed to neural cell survival and differentiation. It will 
be very interesting to test other types of peptides on this scaffold.   
Table 5.1 Functional and phenotypic characteristics of MN derived from mESCs 
References Cell line Method to 
induce MN 
differentiation 
MN 
marker  
MN 
differentiation 
efficiency 
Functional 
test 
Renoncourt 
et al., 1998 
[183] 
mESCs, 
CCE line 
Embryo Body 
(EB) treated 
with RA 
ISL1, 
HB9, 
ChAT 
and 
VAChT 
40–60% of 
Islet1+ 
neurons;12% 
of Islet1+ 
were HB9+ 
N 
Wichterle et 
al., 2002 
[184] 
mESCs, 
HBG3 line 
EB treated 
with RA and 
SHH 
Hoxc6, 
Hoxc7, 
Hoxc8, 
Nkx6.1, 
Olig2, 
Lhx3, 
Lim1, 
ISL1, 
VAChT, 
ChAT 
20–30% of 
neurons were 
HB9+ 
Y 
Deshpande 
et al., 2006 
[185] 
mESCs, 
HBG3 line 
EB treated 
with RA and 
SHH 
Lhx3, 
HB9 
35–40% of 
neurons were 
ChAT+ 
Y 
Hamada et 
al., 2006 
[186] 
mESCs, 
E14.1 line 
transfected 
with 
MASH1 
EB treated 
with RA 
ISL1, 
Lim 1/2, 
HB9 
50% of 
MASH1 
transfected 
cells were 
Islet1+ 
neurons 
Y 
López-
González et 
al., 2009 
[187] 
mESCs, 
HBG3 line 
EB treated 
with RA and 
SHH 
ISL1, 
ChAT 
15–20 % of 
neurons were 
GFP+MN 
Y 
Wu et al., 
2011 [188] 
mESCs 
from a 
SMA 
animal 
model 
EB treated 
with Noggin, 
RA and SHH 
ISL1, 
HB9 and 
ChAT 
40–50% MN N 
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